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 Molecular containers have been a topic of interest for chemists since the 
discovery of crown ethers and their molecular recognition properties in the late 
1960’s. Since then, the field of molecular containers has expanded rapidly to include 
many high affinity and highly selective host molecules. Chapter 1 introduces common 
molecular containers and goes on to discuss the CB[n] family of molecular 
containers. The CB[n] family are an exemplary group of hosts because they exhibit 
extremely high affinities (Ka values up to 1017 M-1) and high selectivity towards their 
guests which make them excellent candidates for many supramolecular applications. 
In order to maximize the use of CB[n], it became important to access specialized and 
functionalized derivatives to cater to various applications and chemistry. Early 
functionalization routes were limited by a lack of mechanistic understanding, but the 
  
mechanistic work of the Isaacs, Kim, and Day groups led to more successful 
syntheses.  
 Chapter 2 discusses a building block synthesis towards water-soluble CB[7] 
derivatives Me2CB[7] and CyCB[7]. The recognition properties of Me2CB[7] are 
investigated as well as its use in drug solubilization. It is found that Me2CB[7], 
though 10 times more water soluble than CB[7], is able to solubilize drugs only as 
well as CB[7].  Additionally, a route towards a monofunctionalized CB[7] derivative, 
Cl-CB[7], bearing a primary chloride which is able to undergo further 
functionalization to a clickable azide by SN2 chemistry is presented. A click reaction 
with a small alkyne is performed resulting in a self-associating host whose self-
assembly process is further investigated. 
 Chapter 3 discusses a building block synthesis towards the first water-soluble 
CB[8] hosts Me4CB[8] and Cy2CB[8]. Mechanistic details of the CB[8] formation are 
elucidated from contrasting experiments and the recognition properties of the CB[8] 
derivatives are investigated by 1H NMR spectroscopy and X-ray crystallography. The 
CB[8] derivatives are investigated as potential drug solubilizing agents and it is found 
that they are able to solubilize several larger pharmaceutical molecules whereas 
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Chapter 1: Introduction to Molecular Containers 
 
1.1 Introduction. 
The field of supramolecular chemistry studies the non-covalent interactions 
between molecules and the resulting effects on the properties of supramolecular systems.  
Nature provides many excellent examples of supramolecular systems such as the 
streptavidin-biotin complex, a high affinity protein complex (Kd = 1014).1  The high 
affinity of streptavidin for biotin comes from two important features2: 1) The high shape-
complementarity of the binding pocket for biotin and 2) the eight hydrogen bonds made 
between biotin and the surrounding protein residues.  Researchers in the supramolecular 
field have long tried to design molecules that could mimic the essential elements of 
avidin and other natural receptors in synthetic host-guest systems with the hope of 
achieving similarly impressive high affinity interactions. 
Of major interest in supramolecular chemistry is the design and use of molecular 
containers for a wide variety of applications such as drug solubilization3 and delivery,4 
catalysis,5 signaling,6 protein folding,7 and many others.  This chapter discusses 
commonly used molecular containers and their applications, the cucurbit[n]uril family of 






1.2 Commonly Used Molecular Containers. 
Molecular containers are a wide class of macrocylic molecules which are able to 
bind smaller molecules through non-covalent interactions thereby creating a host-guest 
complex.  The formation of these complexes can impart new properties such as improved 
solubility or stability to the guest and/or host molecules.  This non-covalent approach to 
modification of compounds has led to exciting advances in catalysis, molecular 
switches,8 chemical sensors,9 and drug delivery.  Some common molecular containers 




Figure I-1. Structures of β-cyclodextrin, calix[4]arene, pillar[5]arene, and 18-crown-6. 
 
 
Crown ethers have the distinction of being one of the first examples of a synthetic 
host molecule.  First published by Pedersen in 1967,10 their ability to sequester metal 
cations led to their study and use in catalysis.  The use of these early host molecules, 





















































Nobel Prize in Chemistry in 1987 and helped to establish the field of synthetic 
supramolecular chemistry.  Since then, molecular containers have become more 
specialized and synthetically complex. For example, calixarenes are composed of meta 
methylene-linked phenols with bulky alkyl groups in the para position, creating a bowl-
shaped cavity that is able to bind hydrophobic guests and alkyl ammonium ions.  
Pillararenes, first synthesized in 2008 by Ogoshi and co-workers,11 are structurally 
similar to calixarenes, but their para-linked hydroquinone groups create a highly 
symmetrical pillar-shaped molecule.  Interestingly, pillararenes display planar chirality 
based on the direction of the hydroquinone functionality, allowing for optically active 
containers. Pillararenes featuring small hydroquinone functionalities can racemize 
between enantiomers while pillararenes featuring bulky groups, such as cyclohexyl, can 
be isolated as individual enantiomers.12   
Cyclodextrins are one of the most commercially available molecular containers 
(in everyday life and in the laboratory setting) due to their low-cost synthesis. They are 
composed of linked dextrose units and can also bind hydrophobic molecules and alkyl 
ammonium ions.  In addition to being cost effective, cyclodextrins are also easily 
functionalized and are soluble in many solvents which makes them prime candidates for 
various applications from household products such as Febreze™ and sensors13 in 
chemical research to pharmaceutical products such as Sugammadex and Captisol.14  
Cyclodextrins have served as a trail blazing example of achievement for molecular 
containers.  However, a big drawback to the use of cyclodextrins is their lack of 
specificity and modest binding affinities towards guests.  These limitations have inspired 





decade alone, there has been an increase in the synthesis of new families of molecular 
containers with incredible recognition properties. 
 
1.3 The Cucurbit[n]uril Family of Molecular Containers. 
In 1905, Behrend et.  al.  reported the synthesis of a polymeric material from the 
condensation of one equivalent of glycoluril (I-1) with two equivalents of formaldehyde 
in concentrated hydrochloric acid (Scheme I-1).15  The material, which was eventually 
named “Behrend’s Polymer,” was then recrystallized from sulfuric acid, giving a white 
crystalline product.  The crystalline compound was not characterized at the time, but was 
found to form complexes with various metal salts in solution, a process that was 
discovered by the observation of a change in color upon addition of the crystalline 
material to the salt solution.  In 1981, Mock et.  al.  repeated Behrend’s original 
experiment and were able to obtain crystals suitable for X-ray crystallography.16  Mock 
found that the compound was a highly symmetrical pumpkin-shaped macrocycle 
consisting of six glycoluril units bridged together by twelve methylene groups.  The 
compound was named “cucurbituril” after the Latin name for the gourd family, 
cucurbitaceae. 
 
























































 Since Mock’s determination of the structure of cucurbituril, now known as 
cucurbit[6]uril (CB[6]) where 6 represents the number of glycoluril units included in the 
macrocycle, several research groups have worked towards the synthesis and isolation of 
other members of the cucurbit[n]uril (CB[n], n = number of glycoluril units) family and 
elucidation of their recognition properties.  The work of Mock,17 Day,18 Buschmann,19 
Kim,20 Zhu21, and Isaacs22 has led to the synthesis and isolation of CB[5], CB[6], CB[7], 
CB[8], CB[10], and, more recently, CB[14] and the study of many interesting CB[n]-
guest complexes. Today, there are procedures for the isolation of various CB[n] 
congeners and studies which describe the effects of variables such as type and 
concentration of acid and presence of metal cations on the outcome of CB[n]-forming 
reactions.23 
 Cucurbit[n]urils have several unique structural characteristics which contribute to 
their interesting properties.  There are two main features that stabilize and strengthen the 
non-covalent interactions with guests: 1) the highly polar carbonyl-lined portal which 
promotes ion-dipole interactions with electrostatically positive groups and 2) a 
hydrophobic cavity which is well suited to hold the alkyl or aryl bodies of these guests.  
In fact, one of the main driving forces for a CB[n] binding event is the enthalpically 
favorable displacement of high energy water molecules from within the hydrophobic 
cavity by a guest.24  Additionally, the glycoluril backbone is rigid which leads to a high 
selectivity for guests based on the volume and electrostatic properties of the guest.  These 
unique features contribute to the high binding affinities that CB[n] display for their guests 





ammonium or diammonium ions (Figure I-2), while some lower affinity guests include 
metal cations and a variety of neutral organic molecules.   
 
 
Figure I-2.  a) Recognition properties of CB[n].  b) Typical alkyl ammonium guests for 
CB[n]. 
 
The wide range of cavity volumes and portal diameters displayed the CB[n] 
family allow them to be highly selective for very different guests. CB[5], being 
considerably smaller than the rest of the CB[n] family, cannot bind many organic 
molecules due to its too small portal but interestingly has been known to bind to gas 
molecules such as Kr, CO2, CO, O2, and N2, and organic solvents such as methanol and 
acetonitrile.  CB[6] is able to bind a wider variety of guests than CB[5], but still is limited 
by the small cavity and portal size.  For example, CB[6] binds well to smaller alkyl 
ammonium ions such as hexanediammonium (I-6) (Ka = (4.49 ±0.84) × 108 M-1)26, but a 
slightly larger guest such as p-xylylenediammonium ion (I-2) requires the addition of 
heat in order to be fit into CB[6] and the even larger I-3 cannot fit inside CB[6] at all.  
Because of this size limitation, research interests tend to focus on the larger CB[n] 





























































affinity complexes with adamantane ammonium guests (I-3, I-4, and I-5) and other bulky 
compounds and has been the recent focus of binding studies on high-affinity host-guest 
complexes.  In 2014, the Isaacs group published a CB[7]-diamantane guest (I-7) complex 
with an attomolar dissociation constant (Ka = 7.2 x 1017 in pure D2O)25, an unheard of 
value in the world of synthetic receptors and which surpasses the binding affinity of 
avidin for biotin (Ka ≈ 1015).1  CB[8] is also capable of binding these larger guests, and 
even more interestingly CB[8] is large enough to form ternary complexes with two 
identical or different guests.27 
One of the disadvantages of working with CB[n] is that they are poorly water 
soluble with CB[7] being the most soluble (20 mM) and CB[6] and CB[8] the least 
soluble (< 50 µM)28, which can make their use in biological applications, a very 
important area for molecular containers, difficult.  CB[n] are insoluble in organic solvents 
as well, though several CB[n] derivatives have modest solubility in solvents such as 
DMSO.29 
 
1.4 Early Synthesis of Cucurbit[n]uril Derivatives. 
Some of the first attempts towards functionalized CB[n] were performed by the 
groups of Stoddart and Zhu. These groups synthesized functionalized CB[n] from 
functionalized glycoluril units which mostly produced CB[5] and CB[6] derivatives.  For 
example, in 1992 Stoddart and coworkers published the synthesis of Me10CB[5] from the 
homomeric cyclization of dimethyl glycoluril (I-1Me)and formaldehyde in HCl in low 
yield, a process which was later improved by Day and coworkers (Scheme I-2).30  






Scheme I-2.  Synthesis of Me5CB[10] from I-1Me and formaldehyde.  
 
One of the limitations to this synthetic approach is that the products are 
preferentially CB[5]-sized.  The small cavity and even smaller portal of CB[5] limits the 
guest interactions which can occur and also limits the possible applications for these 
compounds.  This preference for the formation of smaller products has been attributed to 
the 1,5-diaxial interactions between the substituents on neighboring glycoluril units 
across the 8-membered methylene-bridged rings.  These interactions become more severe 
as the size of the CB[n] increases, limiting the formation of larger products.  
This limitation inspired researchers to investigate the macrocyclization of 
functionalized glycoluril with regular glycoluril to give partially functionalized CB[n].  
Day and coworkers published the synthesis of Me6CB[6] with alternating functionalized 
and unfunctionalized glycoluril units and Me4CB[6] which features two functionalized 
glycoluril units on opposite sides of an ellipsoidal cavity (Scheme I-3).31 Additionally, 
Day published an extensive synthesis of cyclopentano CB[n] (n = 5-7) derivatives based 
on the hypothesis that the slightly strained cyclopentano ring might affect the bond angles 






































Scheme I-3.  Synthesis of heteromeric CB[6] derivatives.  
 
In 2003 Kimoon Kim and coworkers published the synthesis of perhydroxy-
CB[n] ((HO)2nCB[n]) from preformed CB[n].29b  This approach sidesteps the 
complication of separating CB[n] of different sizes from one another by starting out with 
a single size of preformed CB[n].  A radical oxidation reaction is then performed in water 
with potassium persulfate (K2S2O8) which replaces the hydrogen atoms on the equatorial 
methine carbon atoms of the CB[n] with hydroxyl groups to give (HO)2nCB[n] in 40-45% 
yield for CB[5] and CB[6], but < 5% for CB[7] and CB[8] (Scheme I-4).  One of the 
main contributing factors to the medium yield of this procedure is the limited solubility of 
the CB[n] (especially CB[6] and CB[8]) and K2S2O8 in water.  For CB[7] and CB[8], it is 
believed the very low yields are a result of the instability of the perhydroxylated 


















































































further elaborate on these compounds using well-known chemistry to give allyloxy and 
acetyloxy derivatives as pictured in Scheme I-4.  The Kim group has been able to use 
these perhydroxy-CB[n] to do incredible chemistry – such as the covalent attachment of 
CB[6] to glass slides33 and the formation of nanospheres – but the all-over 
functionalization of the perhydroxy-CB[n] limits the control researchers can have over 
subsequent covalent attachments. 
 
 
Scheme I-4.  Synthesis of (HO)12CB[6] from CB[6] and subsequent syntheses of 
perfunctionalized CB[6] derivatives. 
 
After the publication of (HO)2nCB[n], researchers sought to tame the 
perhydroxylation reaction to give (HO)1CB[n].  In 2012 Scherman and coworkers used 
an imidizolium guest and a variation on Kim’s conditions to synthesize (HO)1CB[6].34  
This approach addressed one of the big problems with the perhydroxy synthesis- the low 
solubility of each reactant.  The presence of the imidazolium guest increases the 

































































































R =                  67%




1) NaH, 2) propionic anhydride
1) NEt3, 2) allyl bromide
K2S2O8 
H2O





more water soluble ammonium persulfate ((NH4)2S2O8).  One of the interesting features 
of this synthesis is that by limiting the equivalents of (NH4)2S2O8, they were able to 
achieve a mixture of (HO)1CB[6] and CB[6] so that the unreacted CB[6] can be isolated 
and recycled into a new reaction.  However, due to the oxidant being the limiting reagent 
and the chromatographic purification the yield of this process is only 12%. Additionally, 
the success of this synthesis requires the use of a specialized guest which limits this 
process to CB[6]. 
 
1.5 Mechanism of Cucurbit[n]uril Formation. 
Before the recent advances in post-functionalization of CB[n], synthetic efforts 
towards CB[n] derivatives and analogues were largely focused on the macrocylization of 
glycoluril units and glycoluril analogues.  However, until the mechanism of CB[n] 
formation was elucidated by the separate and joint efforts of the Isaacs and Day groups 
during the early 2000’s, this approach was incredibly difficult.  Without an understanding 
of the mechanism of CB[n] formation, it was impossible to rationally predict and control 
the outcome of reactions. 
Early mechanistic studies by Isaacs and Day indicated that when glycoluril and 
formaldehyde are heated in acid, they first form the glycoluril dimers I-9S and I-9C.  The 
C-shaped I-9C is the more stable of the two and I-9S can isomerize to I-9C (Scheme I-
5).  It was then hypothesized that the oligomerization continues, forming the compound 
known as Behrend’s polymer.  The polymer, which contains many diastereotopic methine 





hypothesized that this compound could then undergo end-to-end cyclization, yielding 
CB[6] as the major product with other CB[n] homologues as side products. 
 
 
Scheme I-5. Chain-growth cyclo-oligomerization mechanism of CB[n] formation. 
 
Follow-up studies by Isaacs, Kim, and Day uncovered more details of this 
mechanism.35  Day and coworkers resubmitted CB[n] to reaction conditions and found 
that CB[5], CB[6], and CB[7] are stable in reaction conditions and therefore are 
thermodynamic products of the CB[n]-forming reaction while CB[8] decomposes under 
the reaction conditions to give smaller CB[n] products, indicating that CB[8] is a 
kinetically-controlled product.  In particular, the isolation of various lengths of glycoluril 
oligomers I-10C – I-15C and inverted CB[n] homologues by Isaacs, Kim, and coworkers 
suggested that a chain-growth cyclo-oligomerization process may be occurring.  These 
compounds were isolated from a reaction mixture of one equivalent of I-1 and one 
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isolation of these products supported the idea that a chain-growth mechanism is operating 
in this reaction where one equivalent of I-1 and two equivalents of formaldehyde can add 
stepwise to each oligomer, forming longer oligomers.  These C-shaped oligomers (I-12C 
– I-15C) then cyclize with two equivalents of formaldehyde as the ureidyl nitrogen end 
groups are brought closer together by each new glycoluril unit added.  This mechanistic 
theory also accounts for the formation of the isolable nor-seco and inverted CB[n] 
products, as demonstrated in Scheme I-5. 
The Isaacs group has a long history of synthesizing CB[n] derivatives from 
glycoluril building blocks.  For example, compound I-16 is an acyclic CB[n] derivative 
synthesized by electrophilic aromatic substitution between hydroquinone derivatives and 
a partially substituted glycoluril tetramer bis (cyclic ether) (Scheme I-6).36  The multiple 
steps leading to the motor compounds have been performed on multi-gram scales in high 
yield.  The acyclic compound is able to accommodate varieties of larger guests using 
similar binding motifs as classic CB[n], with the addition of aromatic walls which 
facilitate π-π interactions and the water-solubilizing sulfonate arms.  These properties 
make I-16 an excellent drug solubilizing agent, a topic which has been reported on 
frequently by the Isaacs group in collaboration with the group of Prof. Volker Briken.37 
Additionally, the naphthalene-functionalized relative of compound I-16 has been 
investigated as a reversal agent for neuromuscular blockade during anesthesia. It was 
found that the naphthalene relative effectively reverses neuromuscular blockade in mice 
similarly to the cyclodextrins-based product Sugammadex.38 These acyclic derivatives 





of supramolecular chemistry; an example that has inspired increased efforts towards 
functionalized CB[n] derivatives. 
  
  
Scheme I-6. Building block synthesis of acyclic CB[n] congener I-16. 
 
Isaacs and coworkers demonstrated the synthesis of CB[6] derivatives from the 
reaction of nor-seco-CB[6] (ns-CB[6]), a CB[6]-like host missing a single methylene 
bridge, and phthaldialdehyde which yielded a Cs-symmetric CB[6] derivative I-17 with a 
xylene moiety as pictured in Scheme I-7.39  The destruction of the top-bottom symmetry 
of CB[6] created differences in the two carbonyl-lined portals.  Interestingly, single 
diastereomers of host-guest complexes were observed by 1H NMR, indicating that one 
portal was capable of more favorable ion-dipole interactions with a guest than the other. 
 
 











































70 ºC, 3 h
40%
R = (CH2)3SO3Na




































































In 2011, Isaacs and coworkers published the gram-scale templated synthesis of an 
acyclic glycoluril hexamer I-13C from I-1, paraformaldehyde, and I-2 as template in HCl 
(Scheme I-8).40  Compound I-13C precipitates from the reaction mixture as the complex 
with I-2, which is easily removed by subsequent washes with aqueous NaOH and NaOH 
in methanol. The bulk synthesis of this oligomer was an exciting discovery for the CB[n] 
field as it signified an ability to control reaction outcomes and isolate kinetic products on 
a large scale. Additionally, glycoluril hexamer I-13C has four reactive ureidyl nitrogens 
that make it a great building block for the synthesis of larger CB[n] derivatives.  
 
 
Scheme I-8.  Templated synthesis of glycoluril hexamer I-13C. 
 
In the same publication, I-13C was reacted with functionalized phthaldialdehyde 
derivatives to give CB[6] derivatives with an external functional group (Scheme I-9).  
The same reaction was also performed between I-13C and 2,3-
napthalenedicarboxaldehyde to give a fluorescent CB[6] derivative which was later used 
in collaboration with Prof. Pavel Anzenbacher and co-workers for the sensing of 















































































The synthesis of functionalized cucurbit[n]urils has become so important over the 
past few years, that many of these more recent developments overlap with the synthetic 
work presented in the following chapters. In fact, many of the synthetic methods 
presented all aim to supply a solution to the same problems:  1) How can we selectively 
synthesize functionalized CB[n] derivatives?  2) Can we access derivatives of the larger 
CB[n] congeners?  3) Can we improve the solubility properties of CB[n]?  4) Can we do 
all of this and maintain or improve the recognition properties of CB[n]? Fortunately, 
many of these problems have been thoroughly addressed in recent years. The next two 





































































Chapter 2: Synthesis and Self-Assembly Processes of 




In 2012, we published the first example of a mono-functionalized CB[7] 
derivative. On the tail of various functionalized CB[6] derivatives synthesized by the 
Isaacs and Scherman groups, interest in functional CB[n] derivatives increased and the 
lack of CB[7] derivatives left a huge gap in CB[n] research. CB[7] is a more desirable 
molecular container for many applications because it is the most water soluble member of 
the CB[n] family, exhibits unsurpassed binding affinities for its guests, and possesses a 
larger cavity than the more accessible CB[6] which is able to bind a wider variety of 
biologically and chemically relevant guests.  
This results and discussion section is organized as follows.  First, we discuss the 
preparation of CB[7] derivatives Me2CB[7], CyCB[7], and MePhCB[7] by a building 
block approach using glycoluril hexamer II-1 and glycoluril bis(cyclic ethers) II-2.  
Then, we describe their basic properties (e.g. x-ray crystallography, host-guest binding, 
aqueous solubility, and drug solubilization).  Next, we synthesize monofunctionalized 
CB[7] derivatives that contain reactive alkylchloride and azide functional groups.  
Finally, we describe the self-assembly of a CB[7] derivative to yield a cyclic tetrameric 






2.2 Synthesis of Me2CB[7] and CyCB[7]. 
            Given the ready access to gram scale quantities of glycoluril hexamer II-1 and 
glycoluril bis (cyclic ethers) II-2 we decided to investigate their transformation into 
CB[7] derivatives (Scheme II-1).  After much experimentation, we performed the 
reaction between II-1 and II-2Me with added KI in 9 M H2SO4 at 110 ˚C for 30 minutes.41  
Analysis of the crude reaction mixture using p-xylylenediammonium ion (II-3) as 1H 
NMR probe42 showed the presence of a 55:45 ratio of CB[6] and Me2CB[7].  As 
expected, the major competing reaction in this hexamer plus monomer building block 
approach to CB[7] derivatives is the unimolecular cyclization of hexamer to give CB[6].  
Purification of the mixture was achieved by the addition of aqueous KI to an aqueous 
solution of the crude reaction mixture which results in precipitation of most of the CB[6] 
byproduct followed by final purification by treatment with activated carbon to yield 
Me2CB[7] (380 mg) in 31% yield.  A similar reaction was performed between II-1 and 
II-2Cy which delivered CyCB[7] in 18% yield.  We find that Me2CB[7] (≥ 264 mM) and 
CyCB[7] (≥ 181 mM) are significantly more soluble in water than CB[7] itself (20-30 
mM)43 which suggests that they might find utility in applications where highly soluble 
compounds are needed (e.g.  supramolecular polymers or drug solubilization).44  When 
we performed related reactions with II-2Ph or II-2CO2Et we did not observe the formation 
of any CB[7] derivatives but rather observed the formation of CB[6] by unimolecular 
cyclization of II-1.  From our previous work45 we know that II-2Ph and II-2CO2Et are less 
reactive than alkylated glycolurils II-2Me or II-2Cy which makes them less able to 
undergo bimolecular reaction with II-1 to give CB[7] derivatives.  In contrast, however, a 





MePhCB[7] in a 61:30 ratio based on analysis of the crude 1H NMR in the presence of 3.  
Pure MePhCB[7] could only be obtained in a meager 3% yield after Dowex™ ion 
exchange chromatography. 
 
Scheme II-1.  Synthesis of Me2CB[7], CyCB[7], and MePhCB[7].  Conditions: a) 9 M 
H2SO4, 110 ˚C, KI, 30 min. 
 
2.3 Properties of Me2CB[7] Studied by X-ray Crystallography. 
            We were fortunate to obtain single crystals of Me2CB[7] as its Me2CB[7]•II-3 
complex and to solve its structure by X-ray crystallography.  Figure II-1a shows a cross-
eyed stereoview of the structure of one of the Me2CB[7]•II-3 complexes in the crystal.  
In contrast to CB[6] derivatives which display an ellipsoidal deformation through their 
equator upon functionalization,42, 46 the CB[7] derivative Me2CB[7] appears structurally 
similar to CB[7] itself.20  For example, the distance between the ureidyl C=O O-atoms of 
a single glycoluril unit average 6.05 Å (range 5.87 – 6.154 Å) which is comparable to 
that observed for CB[7] (6.05 Å; range 5.913 – 6.114) itself.  Similarly, the dimensions 







































RII-2Me  R,R' = MeII-2Cy  R,R' = (CH2)4
II-2Ph  R,R' = Ph
II-2CO2Et  R,R' = CO2Et
II-2MePh  R = Me, R' = Ph
Me2CB[7]  R,R' = Me
CyCB[7]  R,R' = (CH2)4





distance between the opposing methine C-atoms on each fourth glycoluril on Me2CB[7] 
averages 11.398 Å (range 11.247 – 11.516 Å) whereas CB[7] averages 11.404 Å (range 
11.173 – 11.591 Å).  One structural parameter that is rather different for CB[7] and 
Me2CB[7] is the average distance between ureidyl C=O oxygen atoms on every fourth 
glycoluril at one portal.  For Me2CB[7] the distances average 8.188 Å (range 7.197 – 
9.026 Å; standard deviation = 0.644 Å) whereas for CB[7] the distances average 8.139 Å 
(range 7.553 – 8.718 Å, standard deviation = 0.364 Å).  The glycolurils appear to pivot 
such that one oxygen atom moves inward and one moves outward which results in the 
ureidyl C=O portals undergoing an ellipsoidal deformation.  Overall, the molecular 
structures of CB[7] and Me2CB[7] are similar.  Figure II-1b shows a cross-eyed 
stereoview of the basic packing of individual complexes of Me2CB[7]•II-3 into a square 
array parallel to the xy-plane within the crystal.  The Me groups of two adjacent 
Me2CB[7]•II-3 complexes orient themselves toward each others ureidyl C=O portals.  
The iodide counterions (not depicted) are found at the corners of the square array and 






Figure II-1.  Cross-eyed stereoviews of: a) the x-ray crystal structure of Me2CB[7]•II-3, 
and b) a portion of the crystal lattice showing the three dimensional packing motif.  Color 
code: C, gray; H, white; N, blue; O, red; H-bonds, red-yellow striped. 
 
2.4 Recognition Properties of Me2CB[7] and CyCB[7]. 
            After establishing the basic structural features of Me2CB[7] we decided to 
investigate its molecular recognition properties.  For this purpose, we used guests (II-3 – 
II-11) shown in Figure II-2 which increase in size from hexanediamine II-4 to 
adamantane derivatives II-9 – II-11.  Guests II-3 – II-11 are well known to form 
complexes with unsubstituted CB[7] with binding constants up to 4.2 × 1012 M-1 for 





Me2CB[7]• II-4, Me2CB[7]• II-7, and Me2CB[7]• II-10.  The guest resonances observed 
in 1H NMR spectra are nearly identical in chemical shift to those measured for the 
corresponding CB[7] complexes (Appendix 1) which indicates that the magnetic 
environment inside the cavity of CB[7] and Me2CB[7] are quite similar.  The resonances 
observed in the 1H NMR spectra that correspond to the H-atoms of C2v-symmetric 
Me2CB[7] reflect its lower symmetry.  For example, three doublets of relative integral 
two and one doublet of relative integral one are observed for the upfield shifted H-atoms 
of the diastereotopic CH2-groups of the Me2CB[7]•II-3 complex (Figure II-3a).  The 
main reason for synthesizing CB[7] derivatives is to be able to incorporate them into 
more complex systems while maintaining their recognition properties.  Therefore, we 
viewed it as critical to verify that the high binding constants observed for CB[7] are 
maintained for CB[7] derivatives like Me2CB[7].  For this purpose, we used the 
complexes CB[7]•II-11 and Me2CB[7]•II-11 because the H-atoms adjacent to the 
pyridinium N-atom are located at the ureidyl C=O portal in the complexes.  Given that 
the presence of the two Me groups induce a change in the O•••O distance in the 
substituted glycoluril (vide supra) we thought that these protons might exhibit different 
chemical shifts in the CB[7]•II-11 and Me2CB[7]•II-11 complexes.  Experimentally, we 
find that Hn resonates at 8.95 ppm for CB[7]•II-11 and 8.96 ppm for Me2CB[7]•II-11 
(Appendix 1).  We used 1H NMR competition experiments (Appendix 1) to determine 
that the Ka value for Me2CB[7]•II-11 is 3.2 × 1012 M-1 relative to the known Ka value for 
CB[7]•II-11 (1.98 × 1012 M-1).47  Accordingly, it seems reasonable to expect that CB[7] 











Figure II-3.  1H NMR spectra (400 MHz, D2O, RT) recorded for mixtures of: a) 
Me2CB[7] and II-3 (2 equiv.), b) Me2CB[7] and II-4 (2 equiv.), c) Me2CB[7] and II-7 (2 









































2.5 Stability of Me2CB[7]. 
            Experiments performed by Day and co-workers established that CB[5], CB[6], 
and CB[7] are quite stable under the hot acidic conditions (conc.  HCl, 100 ˚C, 24 h) used 
in their formation.48  Accordingly, we wondered whether the Me substituents on the 
convex face of Me2CB[7] might stabilize cationic intermediates accessible under acidic 
conditions and thereby accelerate decomposition reactions of Me2CB[7].  Figure II-4 
shows a plot of the mole fraction of Me2CB[7] versus time for a solution of Me2CB[7] 
heated at 110 ºC in 9M H2SO4.  Over the course of 6 days, Me2CB[7] completely 
decomposes.  The 1H NMR spectrum of the crude reaction mixture using II-3 as probe 
after 6 days shows the presence of macrocycles with CB[6] sized cavities (≈ 24% of the 
crude mixture).  Electrospray mass spectrometry of the crude reaction mixture allows us 
to identify the presence of comparable amounts of CB[6] and Me2CB[6].  Given that few 
applications require such highly acidic and high temperature conditions, we believe that 
dialkylated CB[7] derivatives will be sufficiently stable in most situations. 
 
Figure II-4.  Plot of the mole fraction of Me2CB[7] upon heating at 110 ºC in 9M H2SO4 





2.6 Drug Solubilization using Me2CB[7]. 
One of the emerging areas for application of CB[n ] molecular containers involves 
their use as solubilizing excipients for insoluble pharmaceutical agents.  Given the high 
solubility of Me2CB[7] in water, we decided to test its ability to solubilize albendazole 
and camptothecin, which have previously been solubilized by unsubstituted CB[7].  
Figure 4 shows the phase solubility diagrams constructed for albendazole with either 
Me2CB[7] or CB[7].  To construct the phase solubility diagrams, we stirred a solution of 
a known concentration of host with an excess of insoluble drug overnight, filtered the 
solution to remove excess insoluble drug, and measured the concentration of soluble drug 
by 1 H NMR using CH3SO3-  as a nonbinding internal standard of known concentration.  
The phase solubility diagrams for albendazole and Me2CB[7] or CB[7] are quite similar 
at low concentrations of container (up to 10 mM).  This result can be explained by the 
fact that the linear region of phase solubility diagrams for 1:1 host:guest complexes obeys 
eq 1, where Ka  is the host· guest binding constant (M−1) and s0  is the intrinsic solubility 
of guest (drug).  Given that s0 for albendazole is the same regardless of which host is used 
and that the Ka values for the CB[7]•albendazole and Me2CB[7]• albendazole are 
expected to be very similar, then the initial slopes should also be very similar, according 
to eq 1.  Somewhat surprisingly, at higher concentrations of Me2CB[7] (e.g., 25− 50 
mM), the concentration of albendazole in solution reaches a plateau of 5.8 mM, which is 
lower than that achieved with 15 mM CB[7] (8.1 mM).  The plateau in the phase 
solubility diagram for Me2CB[7]•albendazole indicates that the complex possesses only 
moderate solubility in water (∼ 5.8 mM).  Why does Me2CB[7], which is far more water 





introduction of the Me groups on the convex face of uncomplexed Me2CB[7] 
dramatically increases its solubility relative to that of CB[7] because they prevent the 
CH•••O interactions between the methine C−H groups on the convex face of one 
container with the ureidyl C=O portals of another container in the solid state, which has 
been implicated as a controlling factor in the solubility trends of CB[n] compounds.37  
Within the Me2CB[7]•albendazole and CB[7]•albendazole complexes, the drug fills the 
cavity and protrudes through the ureidyl C=O portals.  Accordingly, the Me groups 
cannot enhance the solubility of Me2CB[7]•albendazole in the same way as they do 
Me2CB[7].  On the contrary, the presence of the hydrophobic Me groups decreases the 
solubility of Me2CB[7]•albendazole relative to that of CB[7]•albendazole.  A similar 
trend was noted for the solubilization of camptothecin by CB[7] and Me2CB[7] 
(Appendix 1).  These results suggest that a major consideration in the design of CB[n] 
derivatives for use as solubilizing excipients is the incorporation of groups designed to 
enhance the solubility of both the container and its container•drug complexes. 
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2.7 Synthesis of Functionalized Derivatives II-18 – II-20. 
            The following work was performed in collaboration with Dr. Liping Cao. The 
preparation of glycoluril derivative II-12 bearing a primary alkyl chloride is shown in 
Scheme II-2.  First, we react butanedione II-13 with isopropylamine II-14 in Et2O with 
TiCl4 to deliver the known diimine II-15.49  Next, we deprotonated II-15 with LDA in 





69% yield after hydrolytic workup.50  Compound II-16 was transformed into glycoluril 
II-17 by reaction with urea in HCl at room temperature in 35% yield.  Finally, treatment 
of II-16 with formalin in HCl gives II-12 in 68% yield. 
 
Scheme II-2.  Synthesis of glycoluril derivative II-12.  Conditions: a) Et2O, TiCl4, b) 
LDA, THF, Cl(CH2)3I, 69%, c) HCl, urea, 35%,  d) HCl, formalin, 68%. 
 
            With access to gram scale quantities of II-12 we decided to synthesize 
monofunctionalized CB[7] derivative II-18 (Scheme II-3).  The reaction between II-1 
and II-12 was conducted in 9M H2SO4 at 110 ˚C in the presence of KI as developed for 
the synthesis of Me2CB[7], CyCB[7], and MePhCB[7] described above.  The 1H NMR 
spectrum of the crude reaction mixture obtained using II-3 as probe allowed us to 
estimate that II-18 comprised 66% of the crude material.  Purification by Dowex™ ion 
exchange chromatography allowed us to isolate 210 mg II-18 in pure form in 16% yield.  
Clearly, the purification process is far from ideal and we are working to improve the 
process.  We found that II-18 can be transformed into monofunctionalized CB[7] 




























heating with NaN3 in H2O at 80 ºC for 2 days.  Azide II-19 reacts with propargyl 
ammonium chloride (II-21) in the presence of Pericas’ catalyst51 in H2O at 50 ºC to give 
II-20 in 95% yield.  The 1H NMR spectrum of the purified sample of II-20 in the 
presence of II-3 – which is a strong binder for CB[7] sized cavities47 and thereby disrupts 
any potential self-assembly processes of II-20 – is shown in Figure II-5a. 
 
Scheme II-3.  Synthesis of CB[7] derivatives.  Conditions: a) 9M H2SO4, KI, 110 ºC, 

















































































Figure II-5.  1H NMR spectra (400 MHz, D2O) recorded for mixtures of: a) II-20 and II-
3 (1.4 equiv.), b) II-20 (3.3 mM) at 20 ºC, and c) II-20 (3.3 mM) at 80 ºC. 
 
2.8 Self-Assembly of II-20 to Yield Cyclic Tetramer II-204. 
            We anticipated that II-20 which contains both a CB[7] sized cavity and a 
covalently attached triazolyl ammonium ion – which is a good guest for CB[7] sized 
cavities – would undergo self assembly processes in water.  A priori it was hard to predict 
whether supramolecular polymerization processes or formation of discrete cyclic 
assemblies would predominate.52  Figure II-5b shows the 1H NMR spectrum recorded for 
a 3.3 mM solution of II-20 in D2O at room temperature.  A single relatively sharp triazole 
C-H resonance is observed at 6.45 ppm which suggested the formation of a well defined 
assembly.  On the other hand, the upfield region of the spectrum between 2.70 and 1.00 
ppm corresponding to the (CH2)4 linker between the CB[7] moiety and the triazole 





the presence of several different assemblies.  Figure II-5c shows the 1H NMR spectrum 
recorded at 80 ºC which shows that these different groups of resonances coalesce and 
sharpen into four distinct resonances corresponding to each of the four CH2-groups of the 
linking chain.  The fact that the resonances for Ht and Hu are still strongly upfield shifted 
in the 1H NMR spectrum recorded at 80 ºC (Figure II-5b versus II-5c) suggests that the 
assembly II-20n persists at high temperature.  To gain insight into the degree of 
oligomerization (n) of the self-assembled species (II-20n) formed in D2O we performed 
diffusion ordered spectroscopy (DOSY)53 for the monomeric complex II-20•II-3 and for 
the self-assembled species II-20n as shown in Figure II-6.  The diffusion coefficients 
measured using four different resonances for II-20•II-3 and II-20n averaged 2.646 ± 
0.026 × 10-10 m2 s-1 and 1.638 ± 0.045 × 10-10 m2 s-1, respectively (Figure II-6).  The ratio 
of diffusion constants for II-20•II-3 and II-20n is 1.616.  The Stokes-Einstein equation 
(eq.  2) shows the relationship between the diffusion coefficient (D) and the 
hydrodynamic radius (rs) in a medium of viscosity η where kB is Boltzmann’s constant 
and T is temperature.53  If we assume that II-20•II-3 and II-20n are roughly spherical 
then the ratio of the measured diffusion coefficients can be converted into a ratio of 
molecular weights which gives the oligomerization number.  For a trimeric, tetrameric, or 
pentameric assembly theory predicts the ratio D(II-20•II-3) / D(II-20n) = 1.442 (n = 3), 
1.587 (n = 4), and 1.709 (n = 5).  In this manner, the measured ratio of diffusion 
coefficients of 1.616 strongly suggests the formation of cyclic tetramer assembly II-204. 






Figure II-6.  DOSY spectra recorded (600 MHz, D2O, RT) for: a) II-20•II-3, and b) 
cyclic tetramer II-204. 
            To provide additional evidence for the formation of the cyclic tetrameric assembly 
II-204 we performed electrospray ionization mass spectrometry of 100 µM solutions in 
H2O and 100,000 resolution on an LTQ-Orbitrap instrument (ThermoFisher, San Jose, 
CA).  Figure II-7a shows the mass spectrum obtained which shows a 4+ ion at m/z = 
1329.97, a 5+ ion at m/z = 1068.68, and a 6+ at m/z = 894.31.  The 4+ ion corresponds to 
the II-2044+ assembly.  Figure II-7b shows the expansion of the region of the II-2044+ ion 
and Figure II-7c shows the theoretical ion distribution for molecular formula 
C200H228N128O56.  The excellent match between Figure II-7b and II-7c provides strong 





significant intensity in Figure II-7a were observed at m/z = 1068.68 which corresponds to 
[II-204•Na]5+ and m/z = 894.31 which corresponds corresponds to [II-204•Na2]6+.  To 
gain further insight into this system, we isolated ion II-2044+ and performed collisional 
induced dissociation experiments (Figure II-7d).  We observed the cleavage of covalent 
bonds rather than the expected dissociation of non-covalent aggregate II-2044+ into 
smaller non-covalent aggregate ions (e.g.  monomers, dimers, or trimers).  Overall, the 
electrospray mass spectrometric investigations strongly support that II-20 self-assembles 
to give the highly stable cyclic tetrameric aggregate II-2044+. 
 
 
Figure II-7.  Electrospray ionization mass spectra recorded for: a) a solution of II-204 
(100 µM, H2O), b) expansion of the II-2044+ ion region, and c) theoretical distribution 
obtained for the molecular formula C200H228N128O56, and d) mass spectrum obtained upon 






2.9 Enumeration of the Different Diastereomers of II-204.   
 
 
Scheme II-4.  Self-assembly of CB[7] derivative II-20 to give the cyclic tetramer II-204 
as a mixture of diastereomers. 
 
            Although compound II-20 is achiral due to the presence of a mirror plane that 
runs through the equator of the molecule, complexation events that desymmetrize the 
cavity result in the formation of complexes that are enantiomers and the two C=O portals 
can be described as enantiotopic.  Accordingly, when four molecules of II-20  self-











































example, all four Me groups can be pointing up (u,u,u,u-II-204), three up and one down 
(u,u,u,d-II-204), and two different combinations of two up and 2 down (u,u,d,d-II-204 
and u,d,u,d-II-204).54  The various diastereomers are able to interconvert with one another 
by a sequence of dissociation of one of the CB[7]•triazolyl ammonium complexes to give 
a linear tetramer, followed by rotation of the CB[7] group and recomplexation of the 
triazolyl ammonium through the opposite ureidyl C=O portal of the CB[7] moiety.  In 
this way, the averaging of the signals observed in the high temperature 1H NMR spectrum 
shown in Figure II-5c is readily understandable. 
 
2.10 Summary.   
 
            In summary, we have shown that CB[7] derivatives are accessible by a building 
block approach that involves the condensation of glycoluril hexamer II-1 with glycoluril 
bis(cyclic ethers) II-2Me, II-2Cy, II-2MePh, and II-12.  Compounds Me2CB[7] and 
CyCB[7] possess superior solubility in water which makes them well suited as a 
solubilization agent for poorly soluble pharmaceutical agents.  Compound II-18 which 
bears a reactive primary alkylchloride group is the first monofunctionalized CB[7] 
derivative to be reported.  Compound II-18 undergoes further functionalization reactions 
to yield II-19 and subsequently II-20 by click chemistry.  We find that II-20 undergoes a 
self-assembly process in water to yield cyclic tetramer II-14 as established by NMR (VT 
and DOSY) and mass spectrometric measurements. 
            We believe that the implications of this research go well beyond the system 





widely applied CB[n] compound because of its good solubility in water and its 
exceptional binding affinity and selectivity toward its guests in water.  This paper 
provides two water soluble monofunctionalized CB[7] derivatives that are amenable to 
further functionalization reactions by SN2 and click chemistry which promises to allow 
the homogenous covalent attachment of CB[7] to solid phases, macromolecules like 
proteins and polymers, and incorporation into other complex and functional 
(bio)molecular systems.  When that occurs, the continued impact of the CB[n] family of 
molecular containers on the chemical sciences will be significant. 









In the wake of the synthesis of functionalized CB[7], we began to pursue similar 
CB[8] derivatives with the goal of creating water-soluble CB[8] hosts with the same 
recognition properties of CB[8].  Other researchers also continued to look for methods to 
synthesize large CB[n] derivatives bearing functional groups. Most recently, in 2015, 
Bardelang and coworkers published a gram-scale synthesis of (HO)1CB[n] (n = 6, 7, 8) 
which is performed in hydrogen peroxide and acid and irradiated by a light source, 
achieving nearly quantitative conversion (95-98%).55  The ready access to large CB[n] 
derivatives in large quantities is a hopeful sign for the future of CB[n] applications. The 
following research details a building block process towards the first water-soluble CB[8] 




3.2 Synthesis and Characterization of CB[8] Derivatives. 
The successful synthesis of monofunctionalized CB[7] derivatives by reaction of 
III-1 with glycoluril bis(cyclic ethers) III-2Me and III-2Cy encouraged us to adapt this 
chemistry toward CB[8].  Accordingly, we performed the reaction between III-1 and III-






Scheme III-1. Building block synthesis of CB[8] derivatives. 
 
The crude reaction mixture was analyzed by 1H NMR using p-
xylylenediammonium ion (III-3) as probe40 which revealed the presence of CB[6], 
Me2CB[7], and Me4CB[8] in a 5:32:52 ratio.  The purification was challenging and a 
multistep procedure was required.  Initially, the crude reaction mixture was treated with 
disulfonated guest III-4 to form the tight and very slowly dissociating Me2CB[7]•III-4 
complex.  This mixture which contains CB[6], Me2CB[7]•III-4, and Me4CB[8] possibly 
in complex with III-4 was loaded onto a Dowex 50WX2-400 ion exchange column that 
was eluted with formic acid/HCl mixtures.  Complex Me2CB[7]•III-4 which is a neutral 
zwitterion but which bears two external SO3- groups elutes rapidly from the sulfonated 
Dowex resin followed by an admixture of CB[6] and Me4CB[8].  To further enrich the 
Me4CB[8] content of the refined solid, the solid was washed with a mixture of formic 
acid, acetic acid, and acetone.  The refined solid was subsequently treated with activated 
carbon and heated at reflux to yield Me4CB[8] in a pure form (320 mg, 11% yield).  













































III-2Me  R = Me
III-2Cy  R,R=(CH2)4
1.35 eq KI, 6 M HCl
110 ºC, 30 min
































the depicted structure.  For example, the electrospray ionization spectrum established the 
molecular formula C60H60N34O16 corresponding to [Me4CB[8]•III-3]2+ (Appendix 2) 
Figure III-3a and b shows the 1H NMR spectrum recorded for Me4CB[8] on its own and 
as the Me4CB[8]•III-32 complex.  The presence of two Me resonances (f and g) indicates 
that Me4CB[8] is overall C2v symmetric and the observation of five doublets (Ha – He; 
1:2:2:2:1 intensity ratio) in the 4-5 ppm region for the diastereotopic CH2 groups is 
consistent with the depicted structure of Me4CB[8].  The 13C NMR spectrum of 
Me4CB[8] (Appendix 2) displays four C=O resonances which is consistent with the 
depicted structure.  To differentiate spectroscopically between Me4CB[8] and an isomer 
with an identical pattern of 1H and 13C NMR resonances (Appendix 2), we performed 
nuclear Overhauser effect (NOE) measurements which showed enhancement of the half-
intensity resonance for Ha upon irradiation of the methyl (Hf, Hg) resonances which is 
diagnostic for the depicted structure of Me4CB[8].  Cy2CB[8] was prepared and purified 
in an analogous manner and was fully characterized (Appendix 2).  Both CB[8] 
derivatives possess enhanced solubility in water relative to CB[8] itself (Me4CB[8] = 3.1 




3.3 Mechanism of Guest-Assisted Dowex™ Ion Exchange Chromatography 
      The separation of Me4CB[8] from the other reaction products proved to be much 
more challenging than expected for several reasons. First, the reaction conditions only 
yield approximately 50% of the CB[8] product and several varied CB[n] congeners as 
side products  Second, due to the fact that an alkylated CB[8] had never been synthesized 
before, the solubility properties of Me4CB[8] in organic or aqueous media were unknown 
which made recrystallization and other solubility-dependent separation methods, such as 
extractions, difficult. Third, possibly due to the interference of the alkyl groups, Dowex™ 
ion exchange chromatography was unable to efficiently separate Me4CB[8] from the 
smaller methylated CB[n] congeners. The result was a slightly improved mixture 
enriched with Me4CB[8], yet still containing other methylated CB[n] congeners.  Given 
that Dowex™ ion exchange chromatography is regularly a highly effective method for the 
separation of CB[n] congeners, we decided to investigate this issue and design a method 
which would allow for the isolation of any CB[n] derivative by Dowex™ ion exchange 
chromatography.  The separation of sulfonate containing compounds by Dowex™ ion 
exchange chromatography had previously been documented by the Isaacs group.56  It had 
been shown that the presence of sulfonate moieties caused these compounds to elute 
quickly from Dowex™ ion exchange resin, so we decided to introduce guests bearing 
sulfonate moieties to non-covalently modify the elution speed of the alkylated CB[n] 
congeners. 
      The rapid elution of the Me2CB[7]•III-4 complex from the Dowex™ ion 
exchange resin made us wonder if this process could be expanded to purify other CB[n] 




organic byproduct that large quantities (500-700 mg) of pure Me2CB[7]•III-4 complex 
were obtained in the first 400 mL of eluent. Because of these large quantities, we 
attempted to remove III-4 from Me2CB[7] with the aim of using this process to purify 
other CB[n] in the future (for example, improving the purification of Cl-CB[7]). 
However, we found that the formation of the Me2CB[7]•III-4 complex is nearly 
irreversible. A usual method for removal of an alkyl or aryl ammonium guest from a 
CB[n] cavity is to add base to deprotonate the ammonium creating the weaker binding 
amine guest which is easily washed away. However, guest III-4 does not have 
ammonium protons and is not susceptible to base removal. Additionally, the sterically 
large and negatively charged sulfonate groups which make the formation of the 
Me2CB[7]•III-4 complex slow also prevent the dissociation of the complex by creating 
an energy barrier to the removal of guest. This energy barrier is so high that in aqueous 
solution with a 10 equivalent excess of adamantane ammonium ion III-5, an extremely 
strong binder for CB[7] (Ka = 4.23 ± 1.00 × 1012),26 we saw no exchange of guest after 2 
d at reflux. The same solution was placed in a microwave reactor for 6 h at 150 ºC and 
less than 50% of guest was exchanged. Additionally, guest III-4 was added to 
Me2CB[7]•III-5 complex in solution and no exchange occurred at room temperature. 
Under microwave conditions for 1 hour, there was approximately 10% exchange and 
after 3 hours approxiamately 50% of the guest had exchanged.  This indicates that the Ka 
of Me2CB[7] for guest III-4 is less than that of Me2CB[7] for III-5, but that the Kd is in 







Figure III-1. a) Structures of sulfonate guests designed for guest-assisted Dowex 
chromatography and b) structure of Dowex™ resin. 
 
      The fast elution of the Me2CB[7]•III-4 complex can be attributed to two factors: 
1) the sulfonate moieties are repelled by the sulfonate residues on the Dowex ion 
exchange resin and 2) the occupation of the CB[n] portal by the guest prevents proton 
exchange between the carbonyls and the sulfonic acid residues to give CB[n]•H+ and 
sulfonate. Guest III-4 has two sulfonate arms which may contribute to the high energetic 
penalty of removing the guest from the cavity and also prevents III-4 from complexing 
with CB[6]. We decided to design a series of guests (Figure III-1a) that would test these 
factors by asking these questions: 1) if two sulfonate arms are necessary, 2) whether the 
dimethyl ammonium moiety is necessary, 3) whether the volume of the guest has an 
effect, and 4) if both carbonyl portals need to be occupied. It was found that guests with 
only one sulfonate arm and/or only one electrostatically positive binding site (III-6, III-7, 
III-9, III-10) would dissociate on the column and have no noticeable effect on the elution 
speed of the CB[n]. Additionally, deletion of the dimethyl ammonium moiety (III-8) did 



































































3.4 Discerning the Mechanism of Me4CB[8] Formation. 
In an effort to better understand the Me4CB[8] forming reaction and thereby 
improve the scope and yield of this reaction we performed some control experiments.  A 
priori, one can postulate two pathways (Scheme III-2): 1) two equivalents of III-2Me 
undergo dimerization to yield tetramethyl glycoluril dimer III-11 which then reacts with 
III-1 to give Me4CB[8], or 2) the two pairs of NH groups of III-1 reacts with two 
equivalents of III-2Me to give a linear glycoluril octamer bis(cyclic ether) which then 
undergoes unimolecular cyclization to give Me4CB[8].  Experimentally, we reacted III-1 
with III-1157 under our standard reaction conditions and observed mainly CB[6], traces 
of Me2CB[7], but no Me4CB[8].  Accordingly, we believe that Me4CB[8] formation 
predominately follows pathway 2. 
 
 
















































































































































































3.5 Properties of Me4CB[8] and Cy2CB[8] Studied by X-ray Crystallography. 
            We were fortunate to obtain single crystals of Me4CB[8]•III-32, Cy2CB[8]•III-32, 
and Me4CB[8]•III-12 and determine their structures by x-ray crystallography which 
corroborates the structural assignments made by NMR spectroscopy and symmetry 
arguments.  There are several noteworthy aspects of the crystal structures.  For example, 
the complexes exhibit substantial ellipsoidal deformations as measured between opposing 
CH2 groups (Cy2CB[8]•III-32: long axis = 14.00 Å and short axis = 10.95 Å; 
Me4CB[8]•III-12: long axis = 14.37 Å and short axis = 11.21 Å) which can be attributed 
in part to the steric demands of the substituted glycolurils; related deformations have 
previously been noted for Me4CB[6] and its complexes.46  The cyclohexyl rings of 
Cy2CB[8] exist in the boat conformation because of the conformational restraints of the 
bicyclic glycoluril framework enforcing a syn-periplanar dihedral angle (0.51º in the 
crystal).  The two aromatic rings of guest III-3 in the Cy2CB[8]•III-32 complex are 
 
Figure III-2.  Stereoview of the x-ray crystal structure of Me4CB[8]•III-32. Color code: 




arranged in an offset geometry with a mean interplanar separation of 3.71 Å which is ≈ 
0.3 Å longer than that typically ascribed to π•••π interactions.  In the structure of 
Me4CB[8]•III-12, guest III-12 adopts a U-shaped conformation as previously observed 
for CB[8]•III-12.47  The three dimensional packing of the complexes in the crystal 
feature the I- counterions in the interstitial sites between complexes presumably 




Figure III-3. Stereoviews of the x-ray crystal structures of: a) Cy2CB[8]•III-32, and b) 








3.6 Recognition Properties of Me4CB[8]. 
After having qualitatively determined that the CB[8] derivatives share the 
recognition abilities of unsubstituted CB[8] we decided to compare the binding constants 
of Me4CB[8] with those of CB[8] in a quantitative manner.  We hypothesized that the 
ellipsoidal deformation observed in the x-ray crystal structure of Me4CB[8]•III-12 might 
translate into a higher affinity of Me4CB[8] toward ellipsoidal guests compared to 
unsubstituted CB[8].  For this purpose, we allowed Me4CB[8] and CB[8] to compete for 
a limited quantity of guest according to equation 1 and 2.58  We identify resonances for 
Me4CB[8]•guest and CB[8]•guest that can be separately integrated which allows a 
determination of the relative concentrations of Me4CB[8]•guest and CB[8]•guest and by 
use of mass balance expressions we can determine the concentrations of free Me4CB[8] 
























Figure III-5. 1H NMR spectra (D2O, 600 MHz, rt) of: a) Me4CB[8], b) Me4CB[8]•III-32 
and excess III-3, c) Me4CB[8]•III-13 and excess III-13, d) Me4CB[8]•III-12 and excess 


































For example, Figure III-6 shows the 1H NMR spectra recorded at 800 MHz for a 
1:1:1 mixture of CB[8], Me4CB[8], and III-13.  We use the 1H NMR resonances for Hs in 
the CB[8]•III-13 and Me4CB[8]•III-13 complexes which appear at 2.39 and 2.37 ppm 
respectively to determine the complex concentrations.  Substitutions of the concentration 
values into equation 2 allows us to determine Krel (Table III-1).  In this manner, we 
determined that Me4CB[8] binds tighter to guests III-12 (2.52-fold), III-13 (1.16 fold), 
III-15 (2.43 fold) than CB[8] does; in contrast Me4CB[8] binds weaker than CB[8] to 
III-14 (Krel = 0.26).  Finally, we can use equation 3 and the previously determined Ka 
values with unsubstituted CB[8]47 to determine Ka for the Me4CB[8]•guest complexes as 
given in Table III-1.  Unfortunately, the trends in Krel values are not sufficiently clear to 




Figure III-6.  1H NMR spectra (50 mM NaO2CCD3 buffered D2O, pH 4.74, 800 MHz, 






Table III-1.  Values of Krel and Ka for Me4CB[8]•guest complexes. 
Guest Krel Ka (M-1) 
III-12 2.52 1.45 × 1011 
III-14 0.26 1.13 × 1011 
III-13 1.16 1.12 × 1011 
III-15 2.43 4.87 × 109 
 
3.7 Using Me4CB[8] as a Drug Solubilizing Agent.   
Finally, we sought to take advantage of the higher solubility of Me4CB[8] 
compared to CB[8] in a relevant application area.  Accordingly, we decided to investigate 
the ability of Me4CB[8] to act as a solubilizing agent for four insoluble drugs 
(amiodarone, estradiol, tamoxifen, albendazole, Figure III-7).59  Experimentally, we stir a 
solution of a known concentration of Me4CB[8] (or CB[8]) with an excess of insoluble 
drug until equilibrium is reached, filter off the insoluble material, and then measure the 
concentration of drug in solution by 1H NMR integration of drug resonances  relative to 
an internal standard of known concentration.  Multiple measurements at different host 
concentrations are then used to construct a phase solubility diagram.  Figure III-8 shows 







Figure III-7. Structures of drugs used in this study. 
 
Linear PSDs are generally indicative of the formation of soluble, well-defined 1:1 
host-guest complexes.  The slope of linear phase solubility diagrams (PSD) is related to 
the inherent solubility of the drug (s0) and the binding constant (Ka, M-1) for the host-drug 
complex according to equation 4.  The slope of the PSD for Me4CB[8] with amiodarone 
is 0.44 whereas it is too small to measure for CB[8].  Given that the Ka values for 
Me4CB[8] and CB[8] complexes are very similar for soluble guests as shown above it is 
somewhat counterintuitive that Me4CB[8] is the superior solubilizing agent.  In this case, 
the CB[8]•amiodarone complex is formed but is insoluble, hence it is the enhanced 
solubility of Me4CB[8] and its Me4CB[8]•drug complexes relative to CB[8] that is crucial 
for its function as a solubilizing agent.  Similar PSD measurements were done with 
tamoxifen, albendazole, and estradiol (Table III-2).  In all cases, Me4CB[8] was a good 






























Table III-2.  Values of slope and Ka (M-1) derived from the PSDs for solubilization of 




Figure III-8.  Phase solubility diagrams constructed for amiodarone with Me4CB[8] (•) 











Amiodarone 0.44 12100 0 - 
Tamoxifen 0.36 46700 0.36 46700 
β-Estradiol 0.086 10700 0 - 





In summary, we have demonstrated that Me4CB[8] and Cy2CB[8] can be formed 
by the condensation of glycoluril hexamer III-1 with bis (cyclic ethers) III-2 under well 
defined conditions.  The CB[8] derivatives maintain the essential binding features of 
unfunctionalized CB[8] in that they also bind to guests III-3 – III-5 and III-12 – III-16 
and display comparable complexation induced changes in chemical shift.  1H NMR 
competition experiments between Me4CB[8] and CB[8] for a limited quantity of guest 
established that Me4CB[8] displays quite similar binding constants (Ka) compared to 
CB[8].  Finally, Me4CB[8] is a better solubilizing agent than CB[8] for four insoluble 
drugs which can be traced to the enhanced solubility  of the Me4CB[8]•drug complexes.  
In conclusion, we present the first building block strategy that allows the synthesis of 
CB[8] derivatives.  The work, especially in light of the recent report of (HO)1CB[8],55 





Chapter 4: Summary and Future Work 
 
4.1 Summary. 
The science of molecular containers has advanced rapidly in recent years.  The 
recent synthetic advances in CB[n] derivative chemistry has opened up opportunities for 
CB[n] hosts to rival the long-reigning cyclodextrins.  The newly available hosts benefit 
from superior binding properties to cyclodextrins, enhanced solubility over 
unfunctionalized CB[n], and/or cheap large-scale synthetic schemes, making them 
excellent hosts for a variety of applications.  This body of work described new synthetic 
approaches towards functionalized CB[7] and CB[8], an area which had previously been 
largely unexplored.   
Chapter 2 described the building block synthesis of monofunctionalized CB[7] 
derivatives and their physical and recognition properties.  It was found that though 
Me2CB[7] and CyCB[7] are highly water soluble and share many of the same highly 
selective recognition properties as CB[7], the functionalized CB[7] derivatives did not 
make effective drug solubilizing agents.  This chapter also described the synthesis and 
applications of Cl-CB[7].  In chapter 3 we discussed the synthesis of two water-soluble 
CB[8] derivatives, Me4CB[8] and Cy2CB[8], and the mechanism of their formation.  
After investigating their recognition properties by both 1H NMR and x-ray 
crystallography, we demonstrated that the CB[8] derivatives also were capable of 




4.2 Future Work. 
We were able to synthesize larger CB[n] derivatives (n = 7, 8) using a building 
block approach from glycoluril hexamer IV-1 and functionalized glycoluril bis (cyclic 
ethers) IV-2.  Using a similar approach, possibly in combination with a large alkyl 
ammonium guest as template, we may be able to access larger, previously unknown 




Scheme IV-XX.  Proposed synthesis of CB[9] derivatives. 
 
A concern for this synthesis is the stability of the macrocycle, a problem which 
was noted in the synthesis of CB[10]. CB[10] is able to form in reaction mixtures as a 
complex with CB[5] as the guest which both templates the formation of CB[10] and 
stabilizes the product in reaction conditions until it can be isolated. Using a similar 
approach, an alkyl or aryl ammonium guest which can fill the cavity of CB[9] may be 






























































Scheme IV-XX. Proposed templated synthesis of Me6CB[9]. 
 
CB[9] would be an important host as its larger cavity may allow for binding larger 
pharmaceutical agents or the formation of interesting ternary complexes, as can be seen 
with CB[8].  Furthermore, based on the well documented trends of CB[n] solubility, we 
could expect that CB[9] may have solubility properties similar to CB[7] and could be 
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General Experimental Details. Starting materials were purchased from commercial 
suppliers were used without further purification.  Compounds SI1, II-14, II-15, and II-18 
were prepared according to the literature procedures.1-4  Melting points were measured on 
a Meltemp apparatus in open capillary tubes and are uncorrected.  TLC analysis was 
performed using pre-coated plastic plates from Merck. IR spectra were recorded on a 
JASCO FT/IR 4100 spectrometer and are reported in cm-1.  NMR spectra were measured 
on a spectrometers operating at 400, 500, or 600 MHz for 1H and 100, 125, and 150 MHz 
for 13C NMR spectra.  Routine mass spectrometry was performed using a JEOL 
AccuTOF electrospray instrument (ESI).  The mass spectrometric investigations of 204 
were performed using an LTQ-Orbitrap XL (ThermoFisher, San Jose, CA).  
 
Synthetic Procedures and Characterization Data 
 
Compound Me2CB[7]. A mixture of hexamer II-1 (1.000 g, 
1.03 mmol) and KI (0.230 g, 1.35 mmol) were dissolved in 9 M 
aqueous H2SO4 (5 mL) and then treated with dimethyl 
glycoluril bis (cyclic ether) II-2Me (0.260 g, 1.03 mmol). The 
flask was then sealed with a rubber septum and heated at 110 
◦C for 30 min. The homogenous clear orange mixture was poured into a 50 mL centrifuge 
tube and methanol (43 mL) was added, causing a white precipitate to appear. The mixture 
was sonicated for 5 min and then centrifuged at 7200 rpm for 8 min. The supernatant was 
discarded and acetone (45 mL) was added to the centrifuge tube. The mixture was 
sonicated until the solid was resuspended and then centrifuged at 7200 rpm for 8 min. 
The supernatant was discarded and the precipitate was dried under high vacuum 




































p-xylylene diamine and determined to be a mixture of approximately 50:50 
CB[6]:Me2CB[7]. The crude white powder was dissolved in H2O (30 mL) and sonicated 
for 5 min, yielding an orange solution. To this solution, 1 M aqueous KI solution (1.8 
mL) was added. The mixture was shaken thoroughly and allowed to sit at RT for 10 min, 
causing a yellow-white precipitate to form. The mixture was centrifuged at 7200 rpm for 
8 min. The supernatant was poured into methanol (100 mL) and centrifuged at 7200 rpm 
for 8 min. The supernatant was discarded and the solid was dried under high vacuum 
(0.69 g). The solid was redissolved in ultrapure water (30 mL). The solution was treated 
with activated carbon (Fisher Chemical, Norit* Netural, C170-500, 4.00 g). The mixture 
was stirred for 24 h and then filtered. The solution was dried under high vacuum, yielding 
a white solid. After 1H NMR analysis in the presence of II-3, the solid was determined to 
be pure dimethyl-CB[7] (0.380 g, 0.321 mmol, 31% yield). M.p. > 350 ◦C. IR (KBr, cm-
1): 1733s, 1473m, 1321m, 1235m, 1193m, 1117m, 806m. 1H NMR (400 MHz, D2O, as 
Me2CB[7]•3, RT): 6.61 (s, 4H), 5.75-5.65 (m, 14H), 5.60-5.40 (m, 12H), 4.32 (d, J = 
15.6, 4H), 4.26 (d, J = 15.6, 2H), 4.21 (d, J = 15.6, 4H), 4.16 (d, J = 15.6, 4H), 3.90 (s, 
4H), 1.80 (s, 6H). 13C NMR (125 MHz, D2O, RT, 1,4-dioxane as internal standard): δ 
157.3, 157.1, 157.0, 156.1, 78.9, 72.0, 71.9, 71.9, 71.8, 71.7, 71.6, 53.4, 53.0, 52.9, 49.2, 
16.2. ESI-MS (II-3 as guest): m/z 664 ([M• II-3 + 2H]2+). HR ESI-MS (II-3 as guest): 







Compound CyCB[7]. A mixture of hexamer (1.000 g, 1.03 
mmol) and KI (0.230 g, 1.35 mmol) were dissolved in 9 M 
aqueous H2SO4 (5 mL) and then treated with cyclohexyl 
glycoluril bis (cyclic ether) (0.288 g, 1.03 mmol). The flask 
was then sealed with a rubber septum and heated at 110 ◦C for 
30 min. The homogenous clear orange mixture was poured into a 50 mL centrifuge tube 
and methanol (43 mL) was added, causing a white precipitate to appear. The mixture was 
sonicated for 5 min and then centrifuged at 7200 rpm for 8 min. The supernatant was 
discarded and acetone (45 mL) was added to the centrifuge tube. The mixture was 
sonicated until the solid was resuspended and then centrifuged at 7200 rpm for 8 min. 
The supernatant was discarded and the precipitate was dried under high vacuum 
overnight. The crude white powder (1.17 g) was analyzed by 1H NMR in the presence of 
p-xylylene diamine and determined to be a mixture of approximately 66:33 CB[6]: 
CyCB[7]. The crude white powder was dissolved in H2O (40 mL) and sonicated for 5 
min, yielding an orange solution. To this solution, 1M aqueous KI solution (3.0 mL) was 
added. The mixture was shaken thoroughly and allowed to sit at RT for 10 min, causing a 
yellow-white precipitate to form. The mixture was centrifuged at 7200 rpm for 8 min. 
The supernatant was poured into methanol (100 mL) and centrifuged at 7200 rpm for 8 
min. The supernatant was discarded and the solid was dried under high vacuum (0.45 g). 
The solid was redissolved in ultrapure water (30 mL). The solution was treated with 
activated carbon (Fisher Chemical, Norit* Netural, C170-500, 4.00 g). The mixture was 
stirred for 24 h and then filtered. The solution was dried under high vacuum, yielding a 



































determined to be pure CyCB[7] (0.23 g, 0.188 mmol, 18% yield). M.p. > 350 ◦C. IR 
(KBr, cm-1): 1728s, 1476s, 1323m, 1236m, 1193m, 1100w, 806m. 1H NMR (400 MHz, 
D2O, as CyCB[7]• II-3, RT): 6.65 (s, 4H), 5.79 (d, J = 15.6, 2H), 5.75 (d, J = 16.20, 8H) 
5.72 (d, J = 16.2, 4H), 5.59 (d, J = 8.1, 2H), 5.56 (d, J = 8.1, 2H), 5.55-5.45 (m, 8H), 4.30 
(d, J = 15.6, 2H), 4.28 (d, J = 16.2, 4H), 4.26 (d, J = 16.2, 4H), 4.21 (d, J = 16.2, 4H), 
3.94 (m, 4H), 2.31 (m, 4H), 1.52 (s, 4H). 13C NMR (125 MHz, D2O, RT, 1,4-dioxane as 
internal standard): δ 156.4, 156.2, 156.2, 155.9, 76.5, 71.0, 70.9, 70.8, 70.8, 70.7, 70.6, 
52.4, 52.0, 51.9, 48.0, 21.4, 12.8.  ESI-MS (II-3 as guest): m/z 677 ([CyCB[7]• II-3 + 
2H]2+). HR ESI-MS (II-3 as guest): m/z 677.25205 ([CyCB[7] II-•3 + 2H]2+, 
C54H62N30O142+, calcd, for 677.2521). 
 
Compound SI1.  To 1-phenylpropane-1,2-dione (4.84 g, 32.7 mmol) 
was added a solution of urea (7.85 g, 130.8 mmol) in HCl (250 mL, 
0.30 M), and the reaction mixture was capped.  The reaction was then 
stirred at RT for 2 days.  The precipitates were filtered, washed with 
H2O (200 mL) and Et2O (200 mL) sequentially, and then dried under high vacuum to 
yield SI1 as a white solid (6.74 g, 29.1 mmol, 89 %).  The 1H NMR matches that reported 
in the literature.4   
 
Compound II-2MePh.  To a 50 mL flask was added a mixture of SI1 
(812 mg, 3.49 mmol), paraformaldehyde (504 mg, 16.8 mmol) in 9 M 
HCl (20 mL), and the flask was capped with a septum.  The reaction 




mL) was added into the reaction mixture, and stirred for an additional 12 h.  The 
precipitates were filtered, washed with H2O (20 mL) and EtOH (10 mL) sequentially, 
dried under high vacuum to yield compound 2MePh as a white solid (635 mg, 2.01 mmol, 
58 %).  M.p. 289-291 ˚C.  IR (KBr, cm-1): 3442w, 1740s, 1726s, 1469s, 1448m, 1413s, 
1394m, 1385s, 1269m, 1206w, 1176s, 1127w, 1107w, 1079w, 1020s, 992w, 974w, 
945m, 924w, 859m.  1H NMR (400 MHz, DMSO-d6): 7.60-7.50 (m, 3H), 7.50-7.40 (m, 
2H) 5.36 (d, J = 11.2, 2H), 5.31 (d, J = 11.2, 2H), 5.01 (d, J = 11.2, 2H), 4.56 (d, J = 11.2, 
2H), 1.19 (s, 3H). 13C NMR (100 MHz, DMSO-d6): 157.7, 132.8, 129.8, 129.3, 127.7, 
78.1, 73.9, 71.3, 70.5, 19.1  HR-MS: m/z 317.1235 ([M + H]+, calcd. for C15H17N4O4+, 
317.1250). 
 
Compound MePhCB[7]. A mixture of 1 (973 mg, 1.0 
mmol) and KI (224 mg, 1.35 mmol) were dissolved in 9M 
aqueous H2SO4 (5 mL) and then treated with 2MePh (380 
mg, 1.2 mmol).  The flask was then sealed with a rubber 
septum and heated at 110 ˚C for 30 min.  The reaction 
solution was then poured into MeOH (40 mL) which resulted in a gray precipitate.  The 
mixture was centrifuged at 7200 rpm for 5 min.  The supernatant was decanted and the 
precipitate was washed with MeOH (40 mL × 3) and centrifuged at 7200 rpm for 5 min.  
The precipitate was dried under high vacuum to give crude, gray powder (1.32 g, 
including includes 30% of MePh CB[7], 61% of CB[6] and 9% of unidentified products). 
The crude solid was dissolved in a solution of 88% formic acid/0.4 M HCl (1:1, v:v) (10 



































containing 20 cm Dowex 50WX2 ion-exchange resin pretreated with 88% formic 
acid/0.4 M HCl (1:1, v:v).  The column was eluted with 88% formic acid/0.4 M HCl (1:1, 
v:v, 400 mL), and then 88% formic acid/0.6 M HCl (1:1, v:v, 400 mL), and then 88% 
formic acid/0.8 M HCl (1:1, v:v, 400 mL).  The fraction purity was assessed by 1H NMR 
using 3 as a probe.  The appropriate factions were combined and solvent was removed by 
rotary evaporation and dried under high vacuum.  The yellow solid was then washed with 
MeOH (40 mL) and centrifuged at 7200 rpm for 5 min.  The supernatant was decanted 
and the precipitate was dried under high vacuum to give crude compound MePhCB[7] as 
a white powder (36 mg, 0.029 mmol, 2.9%).  M.p. > 300 ˚C.  IR (KBr, cm-1): 3455s, 
3001w, 2923w, 1730s, 1637m, 1472s, 1421m, 1337m, 1321s, 1235s, 1193s, 1101w, 
1024w, 968m, 940w, 892w.  1H NMR (500 MHz, D2O, >1 equiv. 3): 7.70-7.60 (m, 3H), 
7.57 (s, unbound 3), 7.30 (d, J = 6.9, 2H), 6.73 (s, 4H), 5.98 (d, J = 15.9, 2H), 5.90-5.70 
(m, 12H), 5.70-5.45 (m, 10H), 5.41 (d, J = 9.1, 1H), 5.17 (d, J = 9.1, 1H), 4.45-4.10 (m, 
14H), 4.27 (s, unbound 3), 4.02 (s, 4H), 1.20 (s, 3H).  13C NMR (125 MHz, D2O, dioxane 
as internal reference, >1 equiv. 3): 156.9, 156.6, 156.6, 156.5, 156.5, 133.8, 133.7, 130.7, 
130.1, 130.0, 129.6, 129.0, 128.0, 85.0, 80.2, 71.8, 71.7, 71.6, 71.5, 71.3, 71.2, 71.1, 71.1, 
71.0, 53.5, 53.3, 52.8, 52.6, 52.3, 50.7, 49.5, 42.8, 42.3, 18.2 (only 34 of the 39 
resonances expected were observed).  HR-MS: m/z 695.2515 ([M•3+2H]2+, calcd. for 
C49H48N28O14•C8H14N22+, 695.2531). 
 
7-Chloroheptane-2,3-dione. To a solution of N,N’-diisopropyl 1,2-
butanediimine1 (10 g, 64.4 mmol) in 150 mL of THF maintained at 




˚C for another 6 h, followed by addition of a solution of 1-chloro-3-iodopropane (15.6 g, 
76.4 mmol) in THF (20 mL). The reaction was stirred at 0 ˚C for 10 h upon which time 1 
N HCl (320 mL) was added into the reaction mixture, and stirred for an additional 5 h at 
RT.  The THF was removed by rotary evaporation, and the remaining aqueous layer was 
extracted with dichloromethane (300 mL × 3). The combined organic extracts were 
washed with 1 N HCl (200 mL), water (200 mL), and sat. NaHCO3 (200 mL) 
sequentially, and then dried over Na2SO4.  The organic extracts were evaporated to afford 
almost pure compound II-16,2 which was distilled (56-58 ˚C/0.05 mm Hg) to give the 
pure product (7.30 g, 44.9 mmol, 69 %) as yellow oil.   IR (KBr, cm-1): 2952w, 1715s, 
1353w.  1H NMR (400 MHz, CDCl3): 3.54 (t, J = 6.2, 2H), 2.78 (t, J = 6.9, 2H), 2.33 (s, 
3H), 1.85-1.70 (m, 4H).  13C NMR (100 MHz, CDCl3): 198.6, 197.3, 44.4, 34.8, 31.7, 
23.6, 20.3. 
 
Compound II-17.  To compound II-16 (9.4 g, 57.8 mmol) was 
added a solution of urea (10.4 g, 173.4 mmol) in HCl (50 mL, 0.3 
M), and was capped.  The reaction was then stirred at RT for 1 
day.  The precipitates were filtered, washed with H2O (30 mL × 
2) and acetone (30 mL × 2) sequentially, dried under high vacuum to yield II-17 as a 
white solid (5.0 g, 20.3 mmol, 35 %).  M.p. > 194 ˚C (dec.).  IR (KBr, cm-1): 2952w, 
1723s, 1677s, 1502m, 1174m, 1139w, 1046w. 1H NMR (500 MHz, DMSO-d6): 7.19 (s, 
2H), 7.09 (s, 2H), 3.62 (t, J = 6.5, 2H), 1.75-1.65 (m, 2H), 1.65-1.60 (m, 2H), 1.55-1.45 
(m, 2H), 1.34 (s, 3H), ppm. 13C NMR (125 MHz, DMSO-d6): 159.6, 77.2, 75.5, 45.1, 





Compound II-18.  To a flask was added a mixture of II-17 (5.00 
g, 20.3 mmol), formaldehyde (37% in H2O, 7.9 mL), H2O (4.5 
mL), and conc. HCl (15 mL), and was capped.  The reaction was 
then stirred at RT for 23 h upon which time additional H2O (60 
mL) was added into the reaction mixture, and stirred for an additional 5 h.  The 
precipitates were filtered, washed with H2O (200 mL) and EtOH (50 mL) sequentially, 
dried under high vacuum to yield compound II-18 as a white solid (4.6 g, 13.9 mmol, 68 
%).  M.p. > 165 ˚C (dec.).  IR (KBr, cm-1): 3434m, 3013w, 2952w, 2882w, 1721s, 1475s, 
1421s, 1388m, 1305m, 1245m, 1180m, 1146w, 1108w, 1063w, 1019m, 985w, 947w, 
875w. 1H NMR (500 MHz, CDCl3): 5.53 (d, J = 11.1, 2H), 5.51 (d, J = 11.1, 2H), 4.82 
(d, J = 11.1, 2H), 4.76 (d, J = 11.1, 2H), 3.61 (t, J = 6.2, 2H), 2.30-2.20 (m, 2H), 1.95-
1.85 (m, 2H), 1.86 (s, 3H), 1.60-1.50 (m, 2H) ppm. 13C NMR (125 MHz, CDCl3): 157.6, 
75.3, 73.5, 71.1, 70.8, 44.2, 31.9, 28.9, 21.4, 17.2 ppm.  ESI-MS: m/z 331.1 ([M+H]+). 
 
Unsuccessful Reaction Between Hexamer II-1 and II-2Ph. A mixture of II-1 (9.7 mg, 
0.01 mmol) and KI (0.22 mg, 1.35 mmol) were dissolved in 9 M aqueous H2SO4 (0.2 
mL) and then treated with II-2Ph (4.6 mg, 0.012 mmol).  The flask was then sealed with a 
rubber septum and heated at 110 ˚C for 30 min.  The reaction solution was then poured 
into MeOH (3 mL) which resulted in a gray precipitate.  The mixture was centrifuged at 
7200 rpm for 5 min.  The supernatant was decanted and the precipitate was washed with 
MeOH (3 mL × 3) and centrifuged at 7200 rpm for 5 min.  The precipitate was dried 










by 1H NMR using II-3 as a probe which showed that presence of CB[6] (94%) and 
unidentified products (6%). 
 
Unsuccessful Reaction Between Hexamer II-1 and II-2CO2Et. A mixture of II-1 (9.7 mg, 
0.01 mmol) and KI (0.22 mg, 1.35 mmol) were dissolved in 9 M aqueous H2SO4 (0.2 
mL) and then treated with II-2CO2Et (4.5 mg, 0.012 mmol).  The flask was then sealed 
with a rubber septum and heated at 110 ˚C for 30 min.  The reaction solution was then 
poured into MeOH (3 mL) which resulted in a gray precipitate.  The mixture was 
centrifuged at 7200 rpm for 5 min.  The supernatant was decanted and the precipitate was 
washed with MeOH (3 mL × 3) and centrifuged at 7200 rpm for 5 min.  The precipitate 
was dried under high vacuum to give crude, gray powder (11.1 mg).  The precipitate was 
assessed by 1H NMR using 3 as a probe which showed the presence of CB[6] (96%) and 
unidentified products (4%). 
 
Details of the Mass Spectrometric Investigations of II-204.  Aqueous CB7 solution was 
diluted to 100µM and infused directly into an LTQ-Orbitrap XL (ThermoFisher, San 
Jose, CA). Precursor and product ion spectra following collisional induced dissociation at 
varying normalized collision energies (NCE) were acquired at maximum resolution. 
Theoretical spectra and neutral masses were produced using the incorporated Xcalibur 
2.0 software suite. 
 
References:  
1. Kimpe, N. D.; D’Hondt, L.; Stanoeva, E. Tetrahedron Lett. 1991, 32, 3879-3882. 
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Figure II-S1.  1H NMR spectrum recorded (400 MHz, D2O, RT) for the crude reaction 
mixture from the reaction between II-1 and II-2Me in the presence of II-3 as a probe.  1H 
NMR integration of the II-3 binding region (6-7 ppm) allows us to determine the contents 





Figure II-S2.  1H NMR spectrum recorded (400 MHz, D2O, RT) for the crude reaction 
mixture from the reaction between II-1 and II-2Cy in the presence of II-3 as a probe.  1H 
NMR integration of the II-3 binding region (6-7 ppm) allows us to determine the contents 





Figure II-S3.  1H NMR spectrum recorded (400 MHz, D2O, RT) for the crude reaction 
mixture from the attempted cyclization of II-1 and II-2Ph in the presence of an excess of 






Figure II-S4.  1H NMR spectrum recorded (400 MHz, D2O, RT) for the crude reaction 
mixture from the attempted cyclization of II-1 and II- 2CO2Et in the presence of an excess 





Figure II-S5.  1H NMR spectrum recorded (400 MHz, D2O, RT) for the crude reaction 
mixture from the reaction between II-1 and II-2MePh in the presence of II-3 as a probe.  
1H NMR integration of the II-3 binding region (6-7 ppm) allows us to determine the 





Figure II-S6.  1H NMR spectrum recorded (400 MHz, D2O, RT) for the crude reaction 
mixture from the reaction between II-1 and II-12 in the presence of II-3 as a probe.  1H 
NMR integration of the II-3 binding region (6-7 ppm) allows us to determine the contents 





























Figure II-S10.  13C NMR spectrum recorded (125 MHz, D2O, dioxane as internal 






























































Figure II-S19.  1H NMR spectrum recorded (400 MHz, D2O, RT) for a mixture of II-19 







Figure II-S20.  13C NMR spectrum recorded (125 MHz, D2O, dioxane as internal 





Figure II-S21.  1H NMR spectrum recorded (500 MHz, D2O, RT) for a mixture of II-20 






Figure II-S22.  13C NMR spectrum recorded (125 MHz, D2O, dioxane as internal 





Figure II-S23.  Partial DQCOSY 1H NMR spectrum recorded (600 MHz, D2O, RT) for 





Figure II-S24. 1H NMR spectra recorded (D2O, 400 MHz, RT) for : a) II-3 (0.5 mM), b) 
a 1:1 mixture of Me2CB[7] (0.5 mM) and 3 II- (0.5 mM), and c) a 1:2 mixture of 





Figure II-S25. 1H NMR spectra recorded (D2O, 400 MHz, RT) for : a) II-4 (0.5 mM), b) 
a 1:1 mixture of Me2CB[7] (0.5 mM) and II-4 (0.5 mM), and c) a 1:2 mixture of 






Figure II-S26. 1H NMR spectra recorded (D2O, 400 MHz, RT) for : a) II-7 (0.5 mM), b) 
a 1:1 mixture of Me2CB[7] (0.5 mM) and II-7 (0.5 mM), and c) a 1:2 mixture of 





Figure II-S27. 1H NMR spectra recorded (D2O, 400 MHz, RT) for : a) II-6 (0.5 mM), b) 
a 1:1 mixture of Me2CB[7] (0.5 mM) and II-6 (0.5 mM), and c) a 1:2 mixture of 





Figure II-S28. 1H NMR spectra recorded (D2O, 400 MHz, RT) for : a) II-9 (0.5 mM), b) 
a 1:1 mixture of Me2CB[7] (0.5 mM) and II-9 (0.5 mM), and c) a 1:2 mixture of 





Figure II-S29. 1H NMR spectra recorded (D2O, 400 MHz, RT) for : a) II-10 (0.5 mM), 
b) a 1:1 mixture of Me2CB[7] (0.5 mM) and II-10 (0.5 mM), and c) a 1:2 mixture of 





Figure II-S30. 1H NMR spectra recorded (D2O, 400 MHz, RT) for : a) II-8 (0.5 mM), b) 
a 1:1 mixture of Me2CB[7] (0.5 mM) and II-8 (0.5 mM), and c) a 1:2 mixture of 





Figure II-S31. 1H NMR spectra recorded (D2O, 400 MHz, RT) for : a) II-3 (0.5 mM), b) 
a 1:1 mixture of CyCB[7] (0.5 mM) and II-3 (0.5 mM), and c) a 1:2 mixture of CyCB[7] 





Figure II-S32. 1H NMR spectra recorded (D2O, 400 MHz, RT) for : a) II-4 (0.5 mM), b) 
a 1:1 mixture of CyCB[7] (0.5 mM) and II-4 (0.5 mM), and c) a 1:2 mixture of CyCB[7] 





Figure II-S33. 1H NMR spectra recorded (D2O, 400 MHz, RT) for : a) II-10 (0.5 mM), 
b) a 1:1 mixture of CyCB[7] (0.5 mM) and II-10 (0.5 mM), and c) a 1:2 mixture of 





Figure II-S34. 1H NMR spectra recorded (D2O, 400 MHz, RT) for : a) II-3 (0.5 mM), b) 
a 1:1 mixture of CB[7] (0.5 mM) and II-3 (0.5 mM), and c) a 1:2 mixture of CB[7] (0.5 





Figure II-S35. 1H NMR spectra recorded (D2O, 400 MHz, RT) for : a) II-8 (0.5 mM), b) 
a 1:1 mixture of CB[7] (0.5 mM) and II-8 (0.5 mM), and c) a 1:2 mixture of CB[7] (0.5 





Figure II-S36. 1H NMR spectra recorded (D2O, 400 MHz, RT) for : a) II-11 (0.5 mM), 
b) a 1:1 mixture of CB[7] (0.5 mM) and II-11 (0.5 mM), and c) a 1:2 mixture of CB[7] 





Figure II-S37. 1H NMR spectra recorded (D2O, 400 MHz, RT) for : a) II-9 (0.5 mM), b) 
a 1:1 mixture of CB[7] (0.5 mM) and II-9 (0.5 mM), and c) a 1:2 mixture of CB[7] (0.5 





Figure II-S38. 1H NMR spectra recorded (D2O, 400 MHz, RT) for : a) II-4 (0.5 mM), b) 
a 1:1 mixture of CB[7] (0.5 mM) and II-4 (0.5 mM), and c) a 1:2 mixture of CB[7] (0.5 





Figure II-S39. 1H NMR spectra recorded (D2O, 400 MHz, RT) for : a) II-10 (0.5 mM), 
b) a 1:1 mixture of CB[7] (0.5 mM) and II-10 (0.5 mM), and c) a 1:2 mixture of CB[7] 





Figure II-S40. 1H NMR spectra recorded (D2O, 400 MHz, RT) for : a) II-6 (0.5 mM), b) 
a 1:1 mixture of CB[7] (0.5 mM) and II-6 (0.5 mM), and c) a 1:2 mixture of CB[7] (0.5 





Figure II-S41. 1H NMR spectra recorded (D2O, 400 MHz, RT) for : a) II-7 (0.5 mM), b) 
a 1:1 mixture of CB[7] (0.5 mM) and II-7 (0.5 mM), and c) a 1:2 mixture of CB[7] (0.5 





Figure II-S42.  1H NMR spectra recorded (600 MHz, 50 mM buffer, RT) for: a) a 
mixture of CB[7] (0.77 mM), Me2CB[7] (0.77 mM), and II-11 (0.7 mM) b) the same 
sample as part a, but with homodecoupling by irradiation of the signal at 8.02 ppm.  The 
inset shows the integration of the expansion of the deconvoluted spectrum used to 




Details of the Crystal Structure of Me2CB[7]. A colorless prism-like specimen of 
C52H80I2N30O25, approximate dimensions 0.34 mm × 0.43 mm × 0.44 mm, was used for 
the X-ray crystallographic analysis. The X-ray intensity data were measured on a Bruker 
APEX-II CCD system equipped with a graphite monochromator and a MoKα sealed tube 
(λ = 0.71073 Å). Data collection temperature was 200 K. 
 
The total exposure time was 22.73 hours. The frames were integrated with the Bruker 
SAINT software package using a narrow-frame algorithm. The integration of the data 
using an orthorhombic unit cell yielded a total of 104851 reflections to a maximum θ 
angle of 25.00° (0.84 Å resolution), of which 13325 were independent (average 
redundancy 7.869, completeness = 99.8%, Rint = 3.85%, Rsig = 2.87%) and 10588 
(79.46%) were greater than 2σ(F2). The final cell constants of a = 23.750(4) Å, b = 
49.017(8) Å, c = 13.018(2) Å, V = 15155.(4) Å3, are based upon the refinement of the 
XYZ-centroids of 9437 reflections above 20 σ(I) with 4.580° < 2θ < 54.07°. Data were 
corrected for absorption effects using the multi-scan method (SADABS). The calculated 
minimum and maximum transmission coefficients (based on crystal size) are 0.6300 and 
0.7300. 
 
The structure was solved and refined using the Bruker SHELXTL Software Package, 
using the space group P c c n, with Z = 8 for the formula unit, C52H80I2N30O25. The final 
anisotropic full-matrix least-squares refinement on F2 with 1028 variables converged at 
R1 = 7.62%, for the observed data and wR2 = 17.67% for all data. The goodness-of-fit 
was 1.000. The largest peak in the final difference electron density synthesis was 1.436 e-
/Å3 and the largest hole was -1.601 e-/Å3 with an RMS deviation of 0.078 e-/Å3. On the 
basis of the final model, the calculated density was 1.560 g/cm3 and F(000), 7264 e-. 
 
Crystallographic References: APEX2 Version 2010.11-3 (Bruker AXS Inc.)  SAINT 
Version 7.68A (Bruker AXS Inc., 2009)  SADABS Version 2008/1 (G. M. Sheldrick, 
Bruker AXS Inc.)  XPREP Version 2008/2 (G. M. Sheldrick, Bruker AXS Inc.)  XS 
Version 2008/1 (G. M. Sheldrick, Acta Cryst. (2008). A64, 112-122)  XL Version 2008/4 
(G. M. Sheldrick, Acta Cryst. (2008). A64, 112-122)  Platon (A. L. Spek, Acta Cryst. 
(1990). A46, C-34) 
 
Table II-S1. Sample and crystal data for UM2261. 
Identification code 2261 
Chemical formula C52H80I2N30O25 
Formula weight 1779.26 
Temperature 200(2) K 
Wavelength 0.71073 Å 
Crystal size 0.34 × 0.43 × 0.44 mm 
Crystal habit colorless prism 
Crystal system orthorhombic 
Space group P c c n 
Unit cell dimensions a = 23.750(4) Å α = 90° 
 b = 49.017(8) Å β = 90° 




Volume 15155.(4) Å3  
Z 8 
Density (calculated) 1.560 Mg/cm3 
Absorption coefficient 0.924 mm-1 
F(000) 7264 
 
Table II-S2. Data collection and structure refinement for UM2261. 
Diffractometer Bruker APEX-II CCD 
Radiation source sealed tube, MoKα 
Theta range for data collection 2.18 to 25.00° 
Index ranges -28 ≤ h ≤ 28, -57 ≤ k ≤ 58, -15 ≤ l ≤ 15 
Reflections collected 104851 
Independent reflections 13325 [R(int) = 0.0385] 
Coverage of independent 
reflections 99.8% 
Absorption correction multi-scan 
Max. and min. transmission 0.7300 and 0.6300 
Structure solution technique direct methods 
Structure solution program SHELXS-97 (Sheldrick, 2008) 
Refinement method Full-matrix least-squares on F2 
Refinement program SHELXL-97 (Sheldrick, 2008) 
Function minimized Σ w(Fo2 - Fc2)2 
Data / restraints / parameters 13325 / 374 / 1028 
Goodness-of-fit on F2 1.000 
Final R indices 10588 data; I>2σ(I) R1 = 0.0762, wR2 = 0.1708 
 all data R1 = 0.0890, wR2 = 0.1767 
Weighting scheme w=1/[σ2(Fo2)+(0.05P)2+49.67P], P=(max(Fo2,0)+2Fc2)/3 
Largest diff. peak and hole 1.436 and -1.601 eÅ-3 
R.M.S. deviation from mean 0.078 eÅ-3 
 
Rint = Σ|Fo2 - Fo2(mean)| / Σ[Fo2]  
R1 = Σ||Fo| - |Fc|| / Σ|Fo|  
GOOF = S = {Σ[w(Fo2 - Fc2)2] / (n - p)} 1/2  
wR2 = {Σ[w(Fo2 - Fc2)2] / Σ[w(Fo2)2]}1/2 
 
Crystallographic information file for Me2CB[7]•II-3 is available free of charge on ACS 






Figure II-S43. Decomposition of Me2CB[7] in 9M H2SO4 at 110 ˚C. 1H NMR spectra 
recorded (400 MHz, D2O, RT) for aliquots of the reaction mixture in the presence of 





Figure II-S44. Electrospray mass spectrum recorded for the sample from Figure II-S43 








Figure II-S45. Cross-eyed stereoviews of MMFF minimized models of u,u,u,u- II-204: 
a) line bond structure, and b) space filling.  Color-code: C, gray; H, white; N, blue; O, 
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General Experimental Details. Starting materials were purchased from commercial 
suppliers were used without further purification. Melting points were measured on a 
Meltemp apparatus in open capillary tubes and are uncorrected.  IR spectra were recorded 
on a JASCO FT/IR 4100 spectrometer and are reported in cm-1.  NMR spectra were 
measured on spectrometers operating at 400, 600, or 800 MHz for 1H and 125 MHz for 
13C NMR spectra.  Routine mass spectrometry was performed using a JEOL AccuTOF 
electrospray instrument (ESI).  Guest molecules III-6 – III-10 were prepared according 
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Synthetic Procedures and Characterization Data 
Compound Me4CB[8].  Compound III-1 (2.000 g, 2.06 
mmol) was combined with KI (0.460 g, 2.78 mmol) in a 25 
mL round-bottom flask and then 6 M aqueous HCl (10 mL) 
was added and the white heterogeneous mixture was stirred 
and sonicated until all clumps disappeared, about 2 
minutes. Next, III-2Me (1.309 g, 5.15 mmol) was added to the mixture and the flask was 
sealed with a rubber septum and secured with steel wire. The reaction was stirred at 110 
ºC for 30 minutes. After 30 minutes, the dark purple reaction mixture was uncapped and 
poured into a 125 mL Erlenmeyer flask. Methanol (80 mL) was added to the flask 
causing an orange precipitate to appear and then the mixture was stirred for ten minutes 
at room temperature. The mixture was centrifuged (8 minutes at 7500 rpm) in portions in 
50 mL centrifuge tubes. The supernatant was decanted and disposed of.  The crude 
orange solid was washed, by the addition of methanol (40 mL) followed by mixing on the 
vortexer to break up the solid and sonication for 10 minutes. The mixture was then 
centrifuged for 8 minutes at 7500 rpm. This washing procedure was repeated once more 
with methanol (50 mL) and then a third time with acetone (50 mL). The solid was dried 
under vacuum for at least 6 hours to give a yellowish crude material (3.410 g). The crude 
material was analyzed by 1H NMR and found to contain 52% Me4CB[8], 32% Me2CB[7], 
5% CB[6], and the rest was unidentified oligomers and methylated CB[6] derivatives. 
This crude mixture was combined with III-4 (1.425 g) and dissolved in 0.6 M HCl:66% 
formic acid (1:1 v:v; 20 mL). This mixture was loaded onto a column containing Dowex 








































0.6 M HCl:66% formic acid (2 L), followed by 1:1 0.8 M HCl:66% formic acid (2 L), 
and finally 1:1 1.0 M HCl:66% formic acid (1 L, or until material stops eluting).  We 
monitored the composition of the column fractions by 1H NMR spectroscopy by adding 
III-3 as a probe guest and observing the resonances in the 6-7 ppm region of the 
spectrum as described previously (J. Am. Chem. Soc. 2011, 133, 17966).  The fractions 
containing Me4CB[8] were collected and the solvent was removed by rotary evaporation. 
The resulting solid contained largely Me4CB[8] with small amounts of CB[6] and 
methylated CB[6] derivatives. The resulting solid (0.950 g) was stirred in 3:1:0.25 acetic 
acid:formic acid:acetone (20 mL) for 2 d at 40 ºC, causing a precipitate to form. The solid 
was collected by centrifugation, rinsed with acetone, and dried under vacuum. This 
material was found to be nearly pure Me4CB[8] by 1H NMR analysis and was further 
purified by refluxing with activated carbon (1 g, Fisher C170-500) in water (250 mL) for 
1 d. The carbon was filtered and the material was collected by rotary evaporation giving 
pure Me4CB[8] as an off white solid (0.320 g, 0.231 mmol, 11% yield).  M.p. > 350 ◦C. 
IR (KBr, cm-1): 1728s, 1466s, 1317m, 1230s, 1191m, 971m, 829m, 805m. 1H NMR (400 
MHz, D2O, as Me4CB[8]• III-32, RT): 5.80-5.74 (m, 16H), 5.59-5.50 (m, 12H), 4.41 (d, J 
= 16.3, 2H), 4.30 (d, J = 15.6, 4H), 4.24 (d, J = 15.5, 4H), 4.19 (d, J = 15.2, 4H), 1.86 (s, 
6H), 1.85 (s, 6H). 13C NMR (125 MHz, D2O, RT, 1,4-dioxane as internal standard, 3 as 
guest): δ 157.8, 157.4, 156.7, 155.8, 132.9, 127.0, 78.5, 78.0, 73.3, 73.0, 72.4, 71.4, 70.9, 
55.6, 53.5, 52.1, 49.9, 44.6, 42.8, 16.5, 15.7. ESI-MS (III-3 as guest): m/z 761 ([M• III-3 
+ 2H]2+). HR ESI-MS (III-3 as guest): m/z 761.28520 ([Me4CB[8]• III-3 + 2H]2+, 




Compound Cy2CB[8]. Compound III-1 (2.000 grams, 
2.06 mmol) and KI (0.460 g, 2.78 mmol) were combined 
in a 25 mL round-bottom flask with 6M aqueous HCl (10 
mL). The mixture was stirred and sonicated until all 
clumps disappeared, approximately 2 minutes. To this 
mixture III-2Cy (1.442 g, 5.15 mmol) was added and the reaction was sealed with a 
rubber septum and secured with steel wire. The reaction mixture was stirred at 110 ºC for 
30 minutes. After 30 minutes, the reaction was uncapped and the resulting dark purple 
mixture was poured into a 125 mL Erlenmeyer flask. Methanol (80 mL) was added, 
causing a light orange precipitate to appear, and the mixture stirred at room temperature 
for 10 minutes. The mixture was centrifuged (8 minutes at 7500 rpm) in portions in 50 
mL centrifuge tubes. The supernatant was decanted and disposed of. The remaining 
orange solid was washed, by the addition of methanol (40 mL) followed by mixing on the 
vortexer to break up the solid and sonication for 10 minutes. The mixture was then 
centrifuged for 8 minutes at 7500 rpm. This washing procedure was repeated once more 
with methanol (50 mL) and then a third time with acetone (50 mL). The solid was dried 
under vacuum for at least 6 hours to give a yellowish crude material (3.974 g). The crude 
material was analyzed by 1H NMR and found to contain 31% Cy2CB[8], 26% CyCB[7], 
and 42% CB[6] and CB[6] derivatives. The crude solid was combined with III-4 (1.424 
g, 3.27 mmol) and dissolved in 1:1 0.6 M HCl:66% formic acid (15 mL) by sonicating 
for 5 minutes and then gently heating until a clear brown solution was obtained. This 
solution was loaded onto a column containing Dowex 50WX2-400 resin. The compound 








































then 1:1 0.8 M HCl:66% formic acid (1 L), and finally 1:1 1.0 M HCl:66% formic acid 
(1.5 L). We monitored the composition of the column fractions by 1H NMR spectroscopy 
by adding III-3 as a probe guest and observing the resonances in the 6-7 ppm region of 
the spectrum as described previously (J. Am. Chem. Soc. 2011, 133, 17966).  Each eluent 
was collected in 250 mL fractions and selected fractions were combined and concentrated 
by rotary evaporation together. The improved material (325 mg) was stirred in 3:1:0.25 
acetic acid:formic acid:acetone (9.3 mL) for 2 d at 40 ºC, causing a precipitate to form. 
The solid was collected by centrifugation, rinsed with acetone (20 mL), and dried under 
vacuum. This material was found to be approximately 98% Cy2CB[8] and was further 
purified by refluxing with activated carbon (0.5 g) in water (200 mL) for 1 d. The carbon 
was removed by filtration and the filtrate was concentrated by rotary evaporation to give 
Cy2CB[8] as an off-white solid (123 mg, 0.086 mmol, 4% yield). M.p. > 350 ◦C. IR (KBr, 
cm-1): 1711s, 1455m, 1312m, 1225s, 1187s, 969m, 800s. 1H NMR (400 MHz, D2O, as 
Cy2CB[8]• III-32, RT): 6.35 (s, 4H), 5.93 (d, J = 15.2, 4H), 5.79 (d, J = 15.4, 4H), 5.77 
(d, J = 15.7, 4H), 5.65-5.58 (m, 12H), 5.53 (d, J = 8.88, 2H), 5.48 (d, J = 8.88, 2H), 4.33 
(d, J = 15.3, 4H), 4.27 (d, J = 15.5, 4H), 4.25 (d, J = 15.7, 4H), 4.18 (s, excess III-3, 4H), 
3.74 (s, 4H), 2.31 (s, 4H), 2.20 (s, 4H), 1.47 (s, 8H). 13C NMR (125 MHz, D2O, RT, 1,4-
dioxane as internal standard, III-3 as guest): δ 157.8, 157.4, 156.8, 156.4, 133.5, 129.5, 
127.0, 77.4, 76.8, 73.3, 72.5, 71.5, 70.9, 55.7, 53.6, 49.9, 42.7, 42.2, 22.7, 21.6, 13.5, 
13.1.  ESI-MS (III-3 as guest): m/z 788 ([M• III-3 + 2H]2+). HR ESI-MS (III-3 as guest): 





Compound III-4. N, N, N, N-tetramethyl-1,4-benzenedimethanamine 
(14.700 g, 0.076 mol) was dissolved in methanol (120 mL) in a 500 mL 
round bottom flask and stirred at 0 ºC for 15 min. Propane sultone 
(28.009 g, 0.229 mol) was dissolved in methanol (120 mL) and this solution was slowly 
added to the flask over 30 minutes. The reaction was removed from the ice bath and 
stirred at RT for 24 h. The resulting precipitate was collected by vacuum filtration and the 
solid was washed with methanol (100 mL) and dried under high vacuum to give III-4 as 
a white solid (25.163 g, 0.058 mol, 76% yield).  M.p. = 300-302 ºC. IR (ATR, cm-1): 
1486w, 1208m, 1180s, 1037s, 884w, 877w, 750w, 738w. 1H NMR (400 MHz, D2O) 7.70 
(s, 4H), 4.61 (s, 4H), 3.52-3.48 (m, 4H), 3.10 (s, 12H), 2.99 (t, 4H), 2.37-2.29 (m, 4H). 
13C NMR (125 MHz, D2O, RT, 1,4-dioxane as internal standard) δ 133.0, 129.0, 66.9, 
62.0, 49.2, 46.7, 17.7.  ESI-MS: m/z 437 ([M + H]+). HR ESI-MS: m/z 437.1765 ([M + 
H]+, C18H33N2O6S2+, calcd. for 437.1780). 
Attempted reactions between III-1 and III-11 in various acids. Compound III-1 (75 mg, 
0.077 mmol) and KI (17 mg, 0.104 mmol) were placed in a glass vial. Acid (2 M, 4 M, 6 
M HCl; 3 M, 6 M, 9 M H2SO4, 0.38 mL) was added and the mixture stirred until hexamer 
either dissolved or became a smooth heterogeneous mixture. Compound III-11 (42 mg, 
0.093 mmol) was added and the mixture stirred at 80 ºC for 30 min. The reaction mixture 
was precipitated by the addition of 2 mL methanol and centrifuged. The collected solids 
were dried by vacuum. Each mixture was analyzed by 1H NMR using III-3 as probe to 
determine the composition of the mixture.  
Attempted reactions between III-1 and increasing equivalents of III-10. Compound III-







(9M, 0.38 mL) was added and the mixture stirred until III-1 either dissolved or became a 
smooth heterogeneous mixture. Compound III-11 (1.2, 2, or 5 equivalents) was added 
and the mixture stirred at 80 ºC for 30 min. The mixture was precipitated by the addition 
of 2 mL methanol and centrifuged. The collected solids were dried under high vacuum.  
Each mixture was analyzed by 1H NMR using III-3 as a probe to determine the 
composition of the mixture. 
Procedure for binding competition experiments between Me4CB[8], CB[8], and guests. 
Stock solutions of Me4CB[8], CB[8], and guests in 50 mM sodium acetate buffer (pH = 
4.74) were prepared and calibrated by 1H NMR spectroscopy using an internal standard 
of known concentration. Using the calculated concentrations, equimolar amounts of 
Me4CB[8] and CB[8] were combined in an NMR tube. To this mixture, 1 equivalent of 
guest solution was added so that each of the three components was present at a 50 µM 
concentration. The mixture was shaken for a minute and then allowed to sit at room 
temperature for an hour. The mixture was analyzed by 1H NMR spectroscopy (800 
MHz). Integrals for the relevant 1H NMR resonances were obtained using MestReNova 
deconvolution software. 
Procedure for constructing phase solubility diagrams for drugs with CB[8] or 
Me4CB[8]. To a solution of a known concentration of Me4CB[8] or CB[8] in either 50 
mM sodium phosphate buffer (pH = 7.40) or 50 mM sodium acetate buffer (pH = 4.74) 
an excess (3 eq.) of solid drug was added. The heterogeneous mixtures were stirred at 
room temperature for 2d. Each solution was then filtered through a sterile syringe filter 
with a 0.2 µm polyethersulfone membrane into a clean vial. Each solution was analyzed 




as an internal standard. The concentration of solubilized drug was calculated by 






Figure III-S1. 1H NMR spectrum recorded (400 MHz, D2O, RT) for the crude reaction 
mixture from the reaction between III-1 and III-2Me in the presence of III-3 as a probe. 
1H NMR integration of the III-3 binding region (6-7 ppm) allows us to determine the 






Figure III-S2. 1H NMR spectrum recorded (400 MHz, D2O, RT) for the crude reaction 
mixture from the reaction between III-1 and III-2Cy in the presence of III-3 as a probe. 
1H NMR integration of the III-3 binding region (6-7 ppm) allows us to determine the 





Figure III-S3. 1H NMR spectrum recorded (400 MHz, D2O, RT) for the crude reaction 
mixture from the attempted reaction between III-1 and III-11 in the presence of III-3 as 
a probe. Observation of the III-3 binding region (6-7 ppm) allows us to determine the 
contents of the crude mixture. This spectrum shows that no Me4CB[8] formed under 

















Figure III-S6. 1H NMR (400 MHz, D2O, RT) recorded for Cy2CB[8] in the presence of 







Figure III-S7. 13C NMR (125 MHz, D2O, RT) recorded for Cy2CB[8]• III-3 in the 



















Figure III-S10.  Enumeration of the structures of the four different Me4CB[8] isomers, 






















































































































Symmetry:                                 C2v                                                                                 C2v       
13C C=O resonances:      4 (2:2:2:2 ratio)                                       5 (1:2:2:2:1 ratio)










































Symmetry:                                 C2v                                                                                 D2h       
13C C=O resonances:      4 (2:2:2:2 ratio)                                           3 (2:4:2 ratio)





Figure III-S11. a) 1H NMR (600 MHz, D2O, RT) recorded for Me4CB[8].  1D selective 
nuclear Overhauser effect 1H NMR spectrum recorded for Me4CB[8] irradiated at: b) 






Figure III-S12. 1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) III-3 (0.3 mM), 
b) a 1:1 mixture of Me4CB[8] (0.3 mM) and III-3 (0.3 mM), c) a 1:2 mixture of 
Me4CB[8] (0.3 mM) and III-3 (0.6 mM), and d) a 1:3 mixture of Me4CB[8] (0.3 mM) 





Figure III-S13. 1H NMR spectra recorded (D2O, 400 MHz, RT) for: a) III-12 (0.3 mM), 
b) a 1:1 mixture of Me4CB[8] (0.3 mM) and III-12 (0.3 mM), and c) a 1:2 mixture of 





Figure III-S14. 1H NMR spectra recorded (D2O, 400 MHz, RT) for : a) III-14 (0.3 mM), 
b) a 1:1 mixture of Me4CB[8] (0.3 mM) and III-14 (0.3 mM), and c) a 1:2 mixture of 





Figure III-S15. 1H NMR spectra recorded (D2O, 400 MHz, RT) for : a) III-16 (0.3 mM), 
b) a 1:1 mixture of Me4CB[8] (0.3 mM) and III-16 (0.3 mM), and c) a 1:2 mixture of 





Figure III-S16. 1H NMR spectra recorded (D2O, 400 MHz, RT) for : a) III-13 (0.3 mM), 
b) a 1:1 mixture of Me4CB[8] (0.3 mM) and III-13 (0.3 mM), and c) a 1:2 mixture of 





Figure III-S17. 1H NMR spectra recorded (D2O, 400 MHz, RT) for : a) III-15 (0.3 mM), 
b) a 1:1 mixture of Me4CB[8] (0.3 mM) and III-15 (0.3 mM), and c) a 1:2 mixture of 





Figure III-S18. 1H NMR spectra recorded (D2O, 400 MHz, RT) for : a) III-3 (0.3 mM), 
b) a 1:1 mixture of Cy2CB[8] (0.3 mM) and III-3 (0.3 mM), c) a 1:2 mixture of 
Cy2CB[8] (0.3 mM) and III-3 (0.6 mM), and d) a 1:3 mixture of Cy2CB[8] (0.3 mM) and 





Figure III-S19. 1H NMR spectra recorded (D2O, 400 MHz, RT) for : a) III-12 (0.3 mM), 
b) a 1:1 mixture of Cy2CB[8] (0.3 mM) and III-12 (0.3 mM), and c) a 1:2 mixture of 





Figure III-S20. 1H NMR spectra recorded (D2O, 400 MHz, RT) for : a) III-14 (0.3 mM), 
b) a 1:1 mixture of Cy2CB[8] (0.3 mM) and III-14 (0.3 mM), and c) a 1:2 mixture of 





Figure III-S21. 1H NMR spectra recorded (D2O, 400 MHz, RT) for : a) III-16 (0.3 mM), 
b) a 1:1 mixture of Cy2CB[8] (0.3 mM) and III-16 (0.3 mM), c) a 1:2 mixture of 
Cy2CB[8] (0.3 mM) and III-16 (0.6 mM), and d) a 1:3 mixture of Cy2CB[8] (0.3 mM) 





Figure III-S22. 1H NMR spectra recorded (D2O, 400 MHz, RT) for : a) III-13 (0.3 mM), 
b) a 1:1 mixture of Cy2CB[8] (0.3 mM) and III-13 (0.3 mM), and c) a 1:2 mixture of 





Figure III-S23. 1H NMR spectra recorded (D2O, 400 MHz, RT) for : a) III-15 (0.3 mM), 
b) a 1:1 mixture of Cy2CB[8] (0.3 mM) and III-15 (0.3 mM), and c) a 1:2 mixture of 






Figure III-S24. 1H NMR spectra recorded (D2O, 400 MHz, RT) for : a) III-3 (0.3 mM), 
b) a 1:1 mixture of CB[8] (0.3 mM) and III-3 (0.3 mM), c) a 1:2 mixture of CB[8] (0.3 





Figure III-S25. 1H NMR spectra recorded (D2O, 400 MHz, RT) for : a) III-12 (0.3 mM), 
b) a 1:1 mixture of CB[8] (0.3 mM) and III-12 (0.3 mM), and c) a 1:2 mixture of CB[8] 






Figure III-S26. 1H NMR spectra recorded (D2O, 400 MHz, RT) for : a) III-14 (0.3 mM), 
b) a 1:1 mixture of CB[8] (0.3 mM) and III-14 (0.3 mM), and c) a 1:2 mixture of CB[8] 






Figure III-S27. 1H NMR spectra recorded (D2O, 400 MHz, RT) for : a) III-16 (0.3 mM), 
b) a 1:1 mixture of CB[8] (0.3 mM) and III-16 (0.3 mM), and c) a 1:2 mixture of CB[8] 





Figure III-S28. 1H NMR spectra recorded (D2O, 400 MHz, RT) for : a) III-13 (0.3 mM), 
b) a 1:1 mixture of CB[8] (0.3 mM) and III-13 (0.3 mM), and c) a 1:2 mixture of CB[8] 




 Figure III-S29. 1H NMR spectra recorded (D2O, 400 MHz, RT) for : a) III-15 (0.3 
mM), b) a 1:1 mixture of CB[8] (0.3 mM) and III-15 (0.3 mM), and c) a 1:2 mixture of 





Figure III-S30. 1H NMR collected (800 MHz, 50 mM sodium acetate buffered D2O, RT) 






Figure III-S31. 1H NMR collected (800 MHz, 50 mM sodium acetate buffered D2O, RT) 






Figure III-S32. 1H NMR collected (800 MHz, 50 mM sodium acetate buffered D2O, RT) 





Figure III-S33. Phase solubility diagrams constructed for albendazole with Me4CB[8] 
() and CB[8] (o). Conditions: 50 mM sodium acetate buffered D2O (pH = 4.74, RT). 
 
 
Figure III-S34. Phase solubility diagrams constructed for β-estradiol with Me4CB[8] () 





































Figure III-S35. Phase solubility diagrams constructed for tamoxifen with Me4CB[8] () 
and CB[8] (o). Conditions: 50 mM sodium phosphate buffered D2O (pH = 7.4, RT). 
 
Table III-S1.  Values of slope and Ka (M-1) derived from the PSDs for solubilization of 
four drugs with Me4CB[8] or CB[8]. 
Drug Me4CB[8] Slope CB[8] Slope 
Amiodarone 0.44 0 
Tamoxifen 0.36 0.36 
β-estradiol 0.086 0 





















Figure III-S36. 1H NMR (600 MHz, 50 mM sodium phosphate buffered D2O (pH = 7.4), 
RT) recorded for 3 mM Me4CB[8] and solubilized amiodarone with MeSO3H as internal 
standard. Integration of the aromatic peaks a-e of amiodarone allowed us to calculate the 






Figure III-S37. 1H NMR (600 MHz, 50 mM sodium phosphate buffered D2O (pH = 7.4), 







Figure III-S38. 1H NMR (600 MHz, 50 mM sodium phosphate buffered D2O (pH = 7.4), 







Figure III-S39. 1H NMR (600 MHz, 50 mM sodium phosphate buffered D2O (pH = 7.4), 







Figure III-S40. 1H NMR (600 MHz, 50 mM sodium phosphate buffered D2O (pH = 7.4), 





Details of the X-ray crystal structures.  Crystals of the Me4CB[8]•3, Me4CB[8]•5, and 
Cy2CB[8]•3 were obtained by combining host with 1.5 equivalents of guest in a 
minimum volume of H2O followed by the dropwise addition of KI (1 M) until the 
solution became cloudy.  Enough H2O was added to obtain a homogenous solution and 
then the solution was filtered through a 0.22 micron filter and transferred to a clean vial 
which was loosely capped.  Crystals appeared after 2 – 5 days.  We were unable to obtain 
crystals of the uncomplexed macrocycles from acidic water. 
Details of the Crystal Structure of Me4CB[8]•32. A colorless prism-like specimen of 
C68H126I4N36O37, approximate dimensions 0.35 mm × 0.46 mm × 0.52 mm, was used for 
the X-ray crystallographic analysis. Instrument description The X-ray intensity data were 
measured on a Bruker APEX-II CCD system equipped with a graphite monochromator 
and a MoKα sealed tube (λ = 0.71073 Å). Data collection temperature was 100 K. 
 
The total exposure time was 10.10 hours. The frames were integrated with the Bruker 
SAINT software package using a narrow-frame algorithm. The integration of the data 
using a monoclinic unit cell yielded a total of 40940 reflections to a maximum θ angle of 
25.00° (0.84 Å resolution), of which 9169 were independent (average redundancy 4.465, 
completeness = 99.9%, Rint = 2.29%) and 8451 (92.17%) were greater than 2σ(F2). The 
final cell constants of a = 13.8420(15) Å, b = 24.405(3) Å, c = 16.1065(18) Å, β = 
106.6605(13)°, V = 5212.6(10) Å3, are based upon the refinement of the XYZ-centroids 
of 9847 reflections above 20 σ(I) with 4.536° < 2θ < 55.52°. Scaling Data were corrected 
for absorption effects using the multi-scan method (SADABS). The calculated minimum 
and maximum transmission coefficients (based on crystal size) are 0.5350 and 0.6360. 
 
The structure was solved and refined using the Bruker SHELXTL Software Package, 
using the space group P21/n, with Z = 2 for the formula unit, C68H126I4N36O37. Structure 
refinement The final anisotropic full-matrix least-squares refinement on F2 with 774 
variables converged at R1 = 7.86%, for the observed data and wR2 = 17.71% for all data. 
The goodness-of-fit was 1.116. The largest peak in the final difference electron density 
synthesis was 0.826 e-/Å3 and the largest hole was -0.709 e-/Å3 with an RMS deviation of 
0.120 e-/Å3. On the basis of the final model, the calculated density was 1.623 g/cm3 and 
F(000), 2588 e-. 
 
Crystallographic References: Software APEX2 Version 2010.11-3 (Bruker AXS Inc.) 
 SAINT Version 7.68A (Bruker AXS Inc., 2009)  SADABS Version 2008/1 (G. M. 
Sheldrick, Bruker AXS Inc.)  XPREP Version 2008/2 (G. M. Sheldrick, Bruker AXS 
Inc.)  XS Version 2008/1 (G. M. Sheldrick, Acta Cryst. (2008). A64, 112-122)  XL 
Version 2012/4 (G. M. Sheldrick, (2012) University of Gottingen, Germany)  Platon (A. 
L. Spek, Acta Cryst. (1990). A46, C-34) 
 
Table III-S2. Sample and crystal data for UM2644. 
Identification code 2644 
Chemical formula C68H126I4N36O37 
Formula weight 2547.64 
Temperature 100(2) K 




Crystal size 0.35 × 0.46 × 0.52 mm 
Crystal habit colorless prism 
Crystal system monoclinic 
Space group P21/n 
Unit cell dimensions a = 13.8420(15) Å α = 90° 
 b = 24.405(3) Å β = 106.6605(13)° 
 c = 16.1065(18) Å γ = 90° 
Volume 5212.6(10) Å3  
Z 2 
Density (calculated) 1.623 Mg/cm3 




Table III-S3. Data collection and structure refinement for UM2644. 
Diffractometer Bruker APEX-II CCD 
Radiation source sealed tube, MoKα 
Theta range for data collection 2.13 to 25.00° 
Index ranges -16 ≤ h ≤ 16, -29 ≤ k ≤ 28, -19 ≤ l ≤ 19 
Reflections collected 40940 
Independent reflections 9169 [R(int) = 0.0229] 
Coverage of independent 
reflections 99.9% 
Absorption correction multi-scan 
Max. and min. transmission 0.6360 and 0.5350 
Structure solution technique direct methods 
Structure solution program ShelXS-97 (Sheldrick, 2008) 
Refinement method Full-matrix least-squares on F2 
Refinement program ShelXL-2014 (Sheldrick, 2014) 
Function minimized Σ w(Fo2 - Fc2)2 
Data / restraints / parameters 9169 / 384 / 774 
Goodness-of-fit on F2 1.116 
Final R indices 8451 data; I>2σ(I) R1 = 0.0786, wR2 = 0.1749 
 all data R1 = 0.0828, wR2 = 0.1771 
Weighting scheme w=1/[σ2(Fo2)+(0.0300P)2+59.0000P], P=(Fo2+2Fc2)/3 
Largest diff. peak and hole 0.826 and -0.709 eÅ-3 
R.M.S. deviation from mean 0.120 eÅ-3 
 
Rint = Σ|Fo2 - Fo2(mean)| / Σ[Fo2]  
R1 = Σ||Fo| - |Fc|| / Σ|Fo|  
GOOF = S = {Σ[w(Fo2 - Fc2)2] / (n - p)}1/2  





Details of the Crystallographic Structure of Me4CB[8]•5.  A colorless plate-like 
specimen of C69H109I3N39O32.50, approximate dimensions 0.05 mm × 0.31 mm × 0.35 
mm, was used for the X-ray crystallographic analysis. Instrument description The X-ray 
intensity data were measured on a Bruker APEX-II CCD system equipped with a graphite 
monochromator and a MoKα sealed tube (λ = 0.71073 Å). Data collection temperature 
was 150 K. 
 
The total exposure time was 16.39 hours. The frames were integrated with the Bruker 
SAINT software package using a narrow-frame algorithm. The integration of the data 
using a monoclinic unit cell yielded a total of 101090 reflections to a maximum θ angle 
of 22.50° (0.93 Å resolution), of which 25025 were independent (average redundancy 
4.040, completeness = 99.2%, Rint = 7.90%) and 15101 (60.34%) were greater than 
2σ(F2). The final cell constants of a = 14.6208(14) Å, b = 50.782(5) Å, c = 26.406(3) Å, 
β = 100.4681(11)°, V = 19279.(3) Å3, are based upon the refinement of the XYZ-
centroids of 9966 reflections above 20 σ(I) with 4.487° < 2θ < 39.84°. Scaling Data were 
corrected for absorption effects using the multi-scan method (SADABS). The calculated 
minimum and maximum transmission coefficients (based on crystal size) are 0.6890 and 
0.9480. 
 
The structure was solved and refined using the Bruker SHELXTL Software Package, 
using the space group P21/c, with Z = 8 for the formula unit, C69H109I3N39O32.50. Structure 
refinement The final anisotropic full-matrix least-squares refinement on F2 with 2453 
variables converged at R1 = 9.81%, for the observed data and wR2 = 23.46% for all data. 
The goodness-of-fit was 1.207. The largest peak in the final difference electron density 
synthesis was 1.251 e-/Å3 and the largest hole was -1.267 e-/Å3 with an RMS deviation of 
0.123 e-/Å3. On the basis of the final model, the calculated density was 1.644 g/cm3 and 
F(000), 9720 e-. 
 
Crystallographic References: Software APEX2 Version 2010.11-3 (Bruker AXS Inc.) 
 SAINT Version 7.68A (Bruker AXS Inc., 2009)  SADABS Version 2008/1 (G. M. 
Sheldrick, Bruker AXS Inc.)  XPREP Version 2008/2 (G. M. Sheldrick, Bruker AXS 
Inc.)  XS Version 2008/1 (G. M. Sheldrick, Acta Cryst. (2008). A64, 112-122)  XL 
Version 2012/4 (G. M. Sheldrick, (2012) University of Gottingen, Germany)  Platon (A. 
L. Spek, Acta Cryst. (1990). A46, C-34) 
 
Table III-S4. Sample and crystal data for UM2665. 
Identification code 2665 
Chemical formula C69H109I3N39O32.50 
Formula weight 2385.65 
Temperature 150(2) K 
Wavelength 0.71073 Å 
Crystal size 0.05 × 0.31 × 0.35 mm 
Crystal habit colorless plate 
Crystal system monoclinic 
Space group P21/c 




 b = 50.782(5) Å β = 100.4681(11)° 
 c = 26.406(3) Å γ = 90° 
Volume 19279.(3) Å3  
Z 8 







Table III-S5. Data collection and structure refinement for UM2665. 
Diffractometer Bruker APEX-II CCD 
Radiation source sealed tube, MoKα 
Theta range for data collection 1.60 to 22.50° 
Index ranges -15 ≤ h ≤ 15, -54 ≤ k ≤ 54, -28 ≤ l ≤ 28 
Reflections collected 101090 
Independent reflections 25025 [R(int) = 0.0790] 
Coverage of independent reflections 99.2% 
Absorption correction multi-scan 
Max. and min. transmission 0.9480 and 0.6890 
Structure solution technique direct methods 
Structure solution program XT-2014 (Sheldrick, 2014) 
Refinement method Full-matrix least-squares on F2 
Refinement program ShelXL-2014 (Sheldrick, 2014) 
Function minimized Σ w(Fo2 - Fc2)2 
Data / restraints / parameters 25025 / 1579 / 2453 
Goodness-of-fit on F2 1.207 
Δ/σmax 0.001 
Final R indices 15101 data; I>2σ(I) R1 = 0.0981, wR2 = 0.2107 
 all data R1 = 0.1549, wR2 = 0.2346 
Weighting scheme w=1/[σ2(Fo2)+(0.0600P)2+149.0000P], P=(Fo2+2Fc2)/3 
Largest diff. peak and hole 1.251 and -1.267 eÅ-3 
R.M.S. deviation from mean 0.123 eÅ-3 
 
Rint = Σ|Fo2 - Fo2(mean)| / Σ[Fo2]  
R1 = Σ||Fo| - |Fc|| / Σ|Fo|  
GOOF = S = {Σ[w(Fo2 - Fc2)2] / (n - p)}1/2  




Details of the crystal structure of Cy2CB[8]•32. A colorless plate-like specimen of 
C72H132I4N36O38, approximate dimensions 0.14 mm × 0.16 mm × 0.26 mm, was used for 
the X-ray crystallographic analysis. Instrument description The X-ray intensity data were 
measured on a Bruker APEX-II CCD system equipped with a graphite monochromator 
and a MoKα sealed tube (λ = 0.71073 Å). Data collection temperature was 150 K. 
 
The total exposure time was 19.79 hours. The frames were integrated with the Bruker 
SAINT software package using a narrow-frame algorithm. The integration of the data 
using a triclinic unit cell yielded a total of 18939 reflections to a maximum θ angle of 
26.59° (0.79 Å resolution), of which 18939 were independent (average redundancy 
1.000, completeness = 88.0%) and 14989 (79.14%) were greater than 2σ(F2). The final 
cell constants of a = 14.877(2) Å, b = 16.089(3) Å, c = 24.245(4) Å, α = 80.894(2)°, β = 
89.257(2)°, γ = 68.144(2)°, V = 5311.5(15) Å3, are based upon the refinement of the 
XYZ-centroids of 3501 reflections above 20 σ(I) with 4.741° < 2θ < 49.58°. Scaling Data 
were corrected for absorption effects using the multi-scan method (SADABS). The 
calculated minimum and maximum transmission coefficients (based on crystal size) are 
0.7140 and 0.8370. 
 
The structure was solved and refined using the Bruker SHELXTL Software Package, 
using the space group P-1, with Z = 2 for the formula unit, C72H132I4N36O38. Structure 
refinement The final anisotropic full-matrix least-squares refinement on F2 with 1495 
variables converged at R1 = 7.09%, for the observed data and wR2 = 17.40% for all data. 
The goodness-of-fit was 1.004. The largest peak in the final difference electron density 
synthesis was 2.999 e-/Å3 and the largest hole was -1.602 e-/Å3 with an RMS deviation of 
0.144 e-/Å3. On the basis of the final model, the calculated density was 1.637 g/cm3 and 
F(000), 2664 e-. 
 
Crystallographic References: Software APEX2 Version 2010.11-3 (Bruker AXS Inc.) 
 SAINT Version 7.68A (Bruker AXS Inc., 2009)  SADABS Version 2008/1 (G. M. 
Sheldrick, Bruker AXS Inc.)  XPREP Version 2008/2 (G. M. Sheldrick, Bruker AXS 
Inc.)  XS/XT Version 2014 (G. M. Sheldrick, (2014) University of Gottingen, Germany) 
 XL Version 2014 (G. M. Sheldrick, (2014) University of Gottingen, Germany)  Platon 
(A. L. Spek, Acta Cryst. (1990). A46, C-34) 
 
 
Table III-S6. Sample and crystal data for UM2710. 
Identification code 2710 
Chemical formula C72H132I4N36O38 
Formula weight 2617.73 
Temperature 150(2) K 
Wavelength 0.71073 Å 
Crystal size 0.14 × 0.16 × 0.26 mm 
Crystal habit colorless plate 
Crystal system triclinic 
Space group P-1 




 b = 16.089(3) Å β = 89.257(2)° 
 c = 24.245(4) Å γ = 68.144(2)° 
Volume 5311.5(15) Å3  
Z 2 






Table III-S7. Data collection and structure refinement for UM2710. 
Diffractometer Bruker APEX-II CCD 
Radiation source sealed tube, MoKα 
Theta range for data collection 1.67 to 26.59° 
Reflections collected 18939 
Coverage of independent 
reflections 88.0% 
Absorption correction multi-scan 
Max. and min. transmission 0.8370 and 0.7140 
Structure solution technique direct methods 
Structure solution program ShelXS-97 (Sheldrick, 2008) 
Refinement method Full-matrix least-squares on F2 
Refinement program ShelXL-2014 (Sheldrick, 2014) 
Function minimized Σ w(Fo2 - Fc2)2 
Data / restraints / parameters 18939 / 676 / 1495 
Goodness-of-fit on F2 1.004 
Final R indices 14989 data; I>2σ(I) R1 = 0.0709, wR2 = 0.1623 




Largest diff. peak and hole 2.999 and -1.602 eÅ-3 
R.M.S. deviation from mean 0.144 eÅ-3 
 
R1 = Σ||Fo| - |Fc|| / Σ|Fo|  
GOOF = S = {Σ[w(Fo2 - Fc2)2] / (n - p)} 1/2  
wR2 = {Σ[w(Fo2 - Fc2)2] / Σ[w(Fo2)2]}1/2  
 
Crystallographic information files for Me4CB[8]•II-32, Cy2CB[8]•II-32, and 
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